1 00:00:06,296 --> 00:00:07,531 >> GOOD AFTERNOON. 2 00:00:07,531 --> 00:00:10,901 MY NAME IS DR. CANDICE PRICE, 3 00:00:10,901 --> 00:00:12,936 AND I AM A PROGRAM DIRECTOR AT 4 00:00:12,936 --> 00:00:14,738 THE NATIONAL HEART, LUNG AND 5 00:00:14,738 --> 00:00:16,707 BLOOD INSTITUTE AT NIH. 6 00:00:16,707 --> 00:00:19,776 ON BEHALF OF THE NHLBI OBESITY 7 00:00:19,776 --> 00:00:21,311 WORKING GROUP, I'M EXCITED TO 8 00:00:21,311 --> 00:00:23,613 SERVE AS THE MODERATOR FOR THIS 9 00:00:23,613 --> 00:00:26,984 18TH OBESITY, NUTRITION AND 10 00:00:26,984 --> 00:00:28,318 PHYSICAL ACTIVITY SEMINAR. 11 00:00:28,318 --> 00:00:29,386 PAST PRESENTATIONS HAVE 12 00:00:29,386 --> 00:00:31,054 HIGHLIGHTED A VARIETY OF TOPICS 13 00:00:31,054 --> 00:00:33,023 SUCH AS TECHNOLOGY ASSISTED INTD 14 00:00:33,023 --> 00:00:35,625 VENGSES FOR WEIGHT MANAGEMENT, 15 00:00:35,625 --> 00:00:36,760 FOOD INSECURITY AND COVID-19, 16 00:00:36,760 --> 00:00:40,464 THE ROLE OF TEACHING KITCHENS IN 17 00:00:40,464 --> 00:00:41,098 ADDRESSING NUTRITION 18 00:00:41,098 --> 00:00:42,399 DISPARITIES, HOW TO IMPROVE FOOD 19 00:00:42,399 --> 00:00:43,967 ACCESS AND OBESITY IN BALTIMORE, 20 00:00:43,967 --> 00:00:46,803 THE RELATIONSHIP BETWEEN BODY 21 00:00:46,803 --> 00:00:48,772 WEIGHT, AND CARDIOVASCULAR RISK 22 00:00:48,772 --> 00:00:50,607 AMONG SOUTH ASIAN AMERICANS AND 23 00:00:50,607 --> 00:00:52,642 MOST RECENTLY, DIETARY 24 00:00:52,642 --> 00:00:55,212 BIOMARKERS TO IDENTIFY THE 25 00:00:55,212 --> 00:00:56,079 CARDIOPROTECTIVE MECHANISMS OF 26 00:00:56,079 --> 00:00:58,582 THE DASH DIE E TODAY'S 27 00:00:58,582 --> 00:01:00,884 PRESENTATION BY DR. SADIYA KHAN 28 00:01:00,884 --> 00:01:02,919 IS ENTITLED CARDIOVASCULAR 29 00:01:02,919 --> 00:01:06,256 HEALTH IN THE PERIPARTUM PERIOD, 30 00:01:06,256 --> 00:01:11,361 DRIVERS AND DETERMINANTS. 31 00:01:11,361 --> 00:01:12,696 BEFORE WE START I WANT TO REVIEW 32 00:01:12,696 --> 00:01:16,500 A FEW HOUSEKEEPING ITEMS. 33 00:01:16,500 --> 00:01:17,300 THROUGHOUT THE PRESENTATION AND 34 00:01:17,300 --> 00:01:18,368 Q & A DISCUSSION, PLEASE SEND 35 00:01:18,368 --> 00:01:21,204 ANY QUESTIONS TO THE EMAIL 36 00:01:21,204 --> 00:01:26,977 ADDRESS LISTED ON THE SLIDES. 37 00:01:26,977 --> 00:01:28,311 ONPA@MAIL.NIH.GOV. 38 00:01:28,311 --> 00:01:30,013 OR CLICK ON THE LIVE FEEDBACK AT 39 00:01:30,013 --> 00:01:31,681 THE BOTTOM OF THE VIDEOCAST 40 00:01:31,681 --> 00:01:33,116 SCREEN TO SUBMIT A QUESTION OR 41 00:01:33,116 --> 00:01:34,851 COMMENT. 42 00:01:34,851 --> 00:01:40,791 NOW LET'S INTRODUCE OUR SPEAKER. 43 00:01:40,791 --> 00:01:43,260 DR. SADIYA KHAN IS THE PROFESSOR 44 00:01:43,260 --> 00:01:46,463 OF CARDIOVASCULAR EPIDEMIOLOGY 45 00:01:46,463 --> 00:01:47,464 AND TENURED ASSOCIATE PROFESSOR 46 00:01:47,464 --> 00:01:50,834 OF MEDICINE AND PREVENTIVE 47 00:01:50,834 --> 00:01:52,369 MEDICINE AND DIRECTOR OF THE 48 00:01:52,369 --> 00:01:55,972 CENTER OF POPULATION SCIENCE AND 49 00:01:55,972 --> 00:01:56,973 AGING IN THE LONGEVITY 50 00:01:56,973 --> 00:01:58,442 INSTITUTE. 51 00:01:58,442 --> 00:02:02,112 AND SHE IS A PREVENTIVE 52 00:02:02,112 --> 00:02:03,613 CARDIOLOGIST AT THE NORTD 53 00:02:03,613 --> 00:02:05,549 WESTERN UNIVERSITY FEINBERG 54 00:02:05,549 --> 00:02:07,284 SCHOOL OF MEDICINE. 55 00:02:07,284 --> 00:02:09,152 DR. KHAN'S CLINICAL EXPERTISE 56 00:02:09,152 --> 00:02:12,155 AND RESEARCH FOCUS ON THE 57 00:02:12,155 --> 00:02:13,256 EPIDEMIOLOGY, PREDICTION AND 58 00:02:13,256 --> 00:02:14,458 GENETICS OF CARDIOVASCULAR 59 00:02:14,458 --> 00:02:16,159 DISEASE WITH A FOCUS ON 60 00:02:16,159 --> 00:02:17,994 PREGNANCY-SPECIFIC RISK FACTORS. 61 00:02:17,994 --> 00:02:19,596 DR. KHAN'S RESEARCH EFFORTS ARE 62 00:02:19,596 --> 00:02:20,931 SUPPORTED BY THE MULTIPLE GRANTS 63 00:02:20,931 --> 00:02:22,399 FROM THE NATIONAL INSTITUTES OF 64 00:02:22,399 --> 00:02:23,967 HEALTH AND THE AMERICAN HEART 65 00:02:23,967 --> 00:02:25,402 ASSOCIATION. 66 00:02:25,402 --> 00:02:27,304 DR. KHAN HAS PUBLISHED OVER 300 67 00:02:27,304 --> 00:02:28,705 PEER REVIEWED SCIENTIFIC 68 00:02:28,705 --> 00:02:30,440 RESEARCH PUBLICATIONS IN LEADING 69 00:02:30,440 --> 00:02:32,509 MEDICAL JOURNALS AND HAS AN H 70 00:02:32,509 --> 00:02:38,315 INDEX OF 41 AS JANUARY OF 2024. 71 00:02:38,315 --> 00:02:40,383 HER ORIGINAL SCIENCE HAS BEEN 72 00:02:40,383 --> 00:02:41,151 HIGHLIGHTED BY THE AMERICAN 73 00:02:41,151 --> 00:02:43,019 HEART ASSOCIATION AS AMONG THE 74 00:02:43,019 --> 00:02:44,454 TOP ADVANCES IN HEART DISEASE 75 00:02:44,454 --> 00:02:46,623 AND STROKE RESEARCH FOR FOUR 76 00:02:46,623 --> 00:02:48,892 CONSECUTIVE YEARS FROM 2020 TO 77 00:02:48,892 --> 00:02:50,460 2023. 78 00:02:50,460 --> 00:02:52,662 WELCOME, DR. KHAN. 79 00:02:52,662 --> 00:02:54,297 >> THANK YOU SO MUCH, DR. PRICE, 80 00:02:54,297 --> 00:02:56,032 FOR THAT KIND INTRODUCTION AND 81 00:02:56,032 --> 00:02:59,636 FOR THE OPPORTUNITY TO -- 82 00:02:59,636 --> 00:03:01,304 YOURSELF AND THE ORGANIZERS TO 83 00:03:01,304 --> 00:03:04,441 PRESENT TODAY. 84 00:03:04,441 --> 00:03:08,044 I HAVE NO RELATIONSHIPS WITH 85 00:03:08,044 --> 00:03:10,480 INDUSTRY AND FUNDING AS NOTED. 86 00:03:10,480 --> 00:03:12,415 SO I WANTED TO START WITH A CASE 87 00:03:12,415 --> 00:03:13,750 PRESENTATION TO SET THE STAGE OF 88 00:03:13,750 --> 00:03:15,385 WHAT WE'RE REALLY TALKING ABOUT 89 00:03:15,385 --> 00:03:17,287 IN TERMS OF CARDIOVASCULAR 90 00:03:17,287 --> 00:03:18,889 HEALTH IN THE PERIPARTUM PERIOD, 91 00:03:18,889 --> 00:03:20,423 AND HOW WE DEFINE IT AND THINK 92 00:03:20,423 --> 00:03:21,291 ABOUT IT. 93 00:03:21,291 --> 00:03:22,859 THIS WAS A PATIENT THAT I SAW A 94 00:03:22,859 --> 00:03:25,328 COUPLE OF YEARS AGO WHO'S 27, 95 00:03:25,328 --> 00:03:27,197 HAD HAD AN UNCOMPLICATED 96 00:03:27,197 --> 00:03:29,833 DELIVERY, AND PRESENTED TO THE 97 00:03:29,833 --> 00:03:30,934 HOSPITAL FIVE DAYS POSTPARTUM 98 00:03:30,934 --> 00:03:32,335 WITH ACUTE SHORTNESS OF BREATH. 99 00:03:32,335 --> 00:03:35,172 HER HEART RATE WAS 90, SHE WAS 100 00:03:35,172 --> 00:03:39,676 HYPERTENSIVE, SHE HAD ELEVATED 101 00:03:39,676 --> 00:03:43,046 JUGULAR VENOUS PRESSURE AND 102 00:03:43,046 --> 00:03:44,581 CHEST X-RAY SHOWN HERE THAT 103 00:03:44,581 --> 00:03:46,483 DEMONSTRATED ACUTE VOLUME 104 00:03:46,483 --> 00:03:48,518 OVERLOAD SO CONSISTENT WITH 105 00:03:48,518 --> 00:03:50,587 ACUTE HEART FAILURE 106 00:03:50,587 --> 00:03:51,021 EXACERBATION. 107 00:03:51,021 --> 00:03:54,558 HER BIOMARKERS WERE CHECKED. 108 00:03:54,558 --> 00:03:59,796 ELEVATED AT 1100 AND TROPONIN 109 00:03:59,796 --> 00:04:02,199 ELEVATED AT 2.5. 110 00:04:02,199 --> 00:04:04,301 WE OBTAINED AN ECHOCARDIOGRAM 111 00:04:04,301 --> 00:04:05,802 THAT DEMONSTRATED OVERALL 112 00:04:05,802 --> 00:04:07,571 PRESERVED EJECTION FRACTION 113 00:04:07,571 --> 00:04:11,007 GIVEN OUR CONCERN FOR PERIPARTUM 114 00:04:11,007 --> 00:04:12,042 CARDIOMYOPATHY BUT THERE WAS A 115 00:04:12,042 --> 00:04:17,080 BIT OF INFRALATERAL HIGH 116 00:04:17,080 --> 00:04:19,382 COKINESIS, OVERALL A PICTURE 117 00:04:19,382 --> 00:04:21,218 CONSISTENT WITH POSTPARTUM 118 00:04:21,218 --> 00:04:22,719 PRE-ECLAMPSIA THIS REALLY LED TO 119 00:04:22,719 --> 00:04:24,721 TWO KEY QUESTIONS THAT BY THE 120 00:04:24,721 --> 00:04:26,256 END OF THIS PRESENTATION, 121 00:04:26,256 --> 00:04:27,691 HOPEFULLY WE'LL BE ABLE TO 122 00:04:27,691 --> 00:04:28,458 ADDRESS. 123 00:04:28,458 --> 00:04:30,760 FIRST, WHAT SHOULD WE COUNSEL 124 00:04:30,760 --> 00:04:32,262 THIS PATIENT ON HER SHORT TERM 125 00:04:32,262 --> 00:04:33,897 AND LONG TERM RISK OF 126 00:04:33,897 --> 00:04:35,565 CARDIOVASCULAR DISEASE, AND TO 127 00:04:35,565 --> 00:04:37,033 FOLLOW THAT UP, WHAT EVIDENCE 128 00:04:37,033 --> 00:04:39,069 HAD BEEN BASED STRATEGIES EXIST 129 00:04:39,069 --> 00:04:43,106 TO REDUCE CARD JOE VASCULAR 130 00:04:43,106 --> 00:04:44,975 DISEASE IN THE PERIPARTUM PERIOD 131 00:04:44,975 --> 00:04:46,843 AND WE'LL COVER THESE WITH SOME 132 00:04:46,843 --> 00:04:47,711 KEY OBJECTIVES IN THE NEXT 133 00:04:47,711 --> 00:04:48,011 SLIDE. 134 00:04:48,011 --> 00:04:54,384 SO HOW DO HE WITHEST WE ANSWER R 135 00:04:54,384 --> 00:04:55,752 AND MANY MORE LIKE LER? 136 00:04:55,752 --> 00:04:56,920 LET'S THINK IN THREE STEPS OVER 137 00:04:56,920 --> 00:04:58,788 THE NEXT 40 MINUTES OR SO. 138 00:04:58,788 --> 00:05:00,457 FIRST, REALLY TRYING TO CLARIFY 139 00:05:00,457 --> 00:05:02,525 WHAT IS THE PERIPARTUM PERIOD 140 00:05:02,525 --> 00:05:04,594 AND WHY IS IT CRITICAL FOR 141 00:05:04,594 --> 00:05:06,596 CARDIOVASCULAR DISEASE RISK IN 142 00:05:06,596 --> 00:05:07,764 BIRTHING INDIVIDUALS? 143 00:05:07,764 --> 00:05:09,499 NEXT, WE'LL DESCRIBE THE 144 00:05:09,499 --> 00:05:10,500 EPIDEMIOLOGY OF ADVERSE 145 00:05:10,500 --> 00:05:12,235 PREGNANCY OUTCOMES AND LOOK TO 146 00:05:12,235 --> 00:05:13,470 SOME OF THE DRIVERS OF THESE 147 00:05:13,470 --> 00:05:15,205 TRENDS. 148 00:05:15,205 --> 00:05:16,940 AND THIRD, DISCUSS THE RATIONALE 149 00:05:16,940 --> 00:05:18,575 FOR CARDIOVASCULAR HEALTH 150 00:05:18,575 --> 00:05:19,809 PROMOTION IN IDENTIFYING 151 00:05:19,809 --> 00:05:21,444 OPPORTUNITIES TO INTERVENE IN 152 00:05:21,444 --> 00:05:25,482 THE PERIPARTUM PERIOD. 153 00:05:25,482 --> 00:05:28,551 SO LET'S GET STARTED WITH THE 154 00:05:28,551 --> 00:05:29,352 PERIPARTUM PERIOD WITHIN THE 155 00:05:29,352 --> 00:05:30,520 CONSTRUCT OF A LIFE COURSE 156 00:05:30,520 --> 00:05:34,224 APPROACH. 157 00:05:34,224 --> 00:05:35,759 IF WE THINK ABOUT THE OVERALL 158 00:05:35,759 --> 00:05:36,860 FEMALE LIFE COURSE AND WE GO TO 159 00:05:36,860 --> 00:05:38,628 THE NEXT SLIDE, WE'LL ZERO IN ON 160 00:05:38,628 --> 00:05:40,897 THE REPRODUCTIVE LIFE COURSE. 161 00:05:40,897 --> 00:05:42,432 IF WE ADVANCE ONE FURTHER, WE'LL 162 00:05:42,432 --> 00:05:44,534 THINK ABOUT THIS ENTIRE PERIOD 163 00:05:44,534 --> 00:05:47,037 AS BEGINNING IN MENARCHE AND 164 00:05:47,037 --> 00:05:48,905 ENDING IN MENOPAUSE IN WHICH AN 165 00:05:48,905 --> 00:05:50,140 INDIVIDUAL WHO IS 166 00:05:50,140 --> 00:05:50,774 PREGNANCY-CAPABLE MAY HAVE ONE 167 00:05:50,774 --> 00:05:52,275 OR MORE PREGNANCIES DURING THIS 168 00:05:52,275 --> 00:05:55,545 TIME PERIOD. 169 00:05:55,545 --> 00:05:57,314 THIS COLLECTIVELY COULD BE 170 00:05:57,314 --> 00:05:58,948 THOUGHT OF AS THE PREPREGNANCY, 171 00:05:58,948 --> 00:06:00,850 PREGNANCY AND POSTPARTUM PERIOD, 172 00:06:00,850 --> 00:06:02,452 WHICH TOGETHER IN AGGREGATE 173 00:06:02,452 --> 00:06:04,120 REPRESENT THE PERIPARTUM PERIOD. 174 00:06:04,120 --> 00:06:05,622 WHICH IS THE FOCUS OF THIS 175 00:06:05,622 --> 00:06:09,125 DISCUSSION. 176 00:06:09,125 --> 00:06:10,894 AS WE THINK ABOUT THIS, LET'S 177 00:06:10,894 --> 00:06:12,529 TAKE THE RIGHT SIDE OF THIS 178 00:06:12,529 --> 00:06:14,597 FIGURE FIRST AND TALK MORE ABOUT 179 00:06:14,597 --> 00:06:16,232 PREGNANCY AND POSTPARTUM WHERE 180 00:06:16,232 --> 00:06:18,101 THERE'S A LOT MORE DATA AND 181 00:06:18,101 --> 00:06:19,169 AWARENESS AROUND ADVERSE 182 00:06:19,169 --> 00:06:20,837 PREGNANCY OUTCOMES IN 183 00:06:20,837 --> 00:06:21,838 CARDIOVASCULAR DISEASE RISK. 184 00:06:21,838 --> 00:06:24,007 SO THAT SHORT TERM PERIOD WHERE 185 00:06:24,007 --> 00:06:25,208 MATERNAL MORBIDITY AND MORTALITY 186 00:06:25,208 --> 00:06:27,911 MAY BE PRESENT, INCLUDING ICU 187 00:06:27,911 --> 00:06:29,279 ADMISSIONS, MORBIDITY, 188 00:06:29,279 --> 00:06:30,547 MORTALITY, ADVERSE PREGNANCY 189 00:06:30,547 --> 00:06:32,849 OUTCOMES, AND HOW IT AFFECT 190 00:06:32,849 --> 00:06:33,850 LONG-TERM MORBIDITY AND 191 00:06:33,850 --> 00:06:36,586 MORTALITY. 192 00:06:36,586 --> 00:06:39,422 IF WE THINK ABOUT PREGNANCY AS A 193 00:06:39,422 --> 00:06:40,724 STRESS TEST, AS IT'S BEEN 194 00:06:40,724 --> 00:06:42,859 COMMONLY CALLED, WE HAVE TO 195 00:06:42,859 --> 00:06:44,060 FIRST UNDERSTAND THAT PREGNANCY 196 00:06:44,060 --> 00:06:47,864 IN AND OF ITSELF LEADS TO MANY 197 00:06:47,864 --> 00:06:49,165 PHYSIOLOGIC VASCULAR AND 198 00:06:49,165 --> 00:06:51,000 METABOLIC CHANGES THAT ARE 199 00:06:51,000 --> 00:06:52,435 APPROPRIATE ADAPTATIONS TO 200 00:06:52,435 --> 00:06:57,040 ACCOUNT FOR THE GROWING FETUS. 201 00:06:57,040 --> 00:06:59,209 UNFORTUNATELY, WHEN THOSE 202 00:06:59,209 --> 00:07:00,977 ADAPTATIONS RESULT IN 203 00:07:00,977 --> 00:07:02,512 PATHOPHYSIOLOGIC CONDITIONS, OR 204 00:07:02,512 --> 00:07:03,713 ADVERSE PREGNANCY OUTCOMES, 205 00:07:03,713 --> 00:07:05,348 WHICH CAN INCLUDE HYPERTENSIVE 206 00:07:05,348 --> 00:07:09,052 DISORDERS OF PREGNANCY OR HDP, 207 00:07:09,052 --> 00:07:10,920 GESTATIONAL DIABETES OR GDM, 208 00:07:10,920 --> 00:07:13,390 PRETERM BIRTH OR PTB HERE OR 209 00:07:13,390 --> 00:07:14,624 SMALL FOR GESTATIONAL AGE IS 210 00:07:14,624 --> 00:07:16,726 WHEN WE SEE THE SIGNAL MOVING ON 211 00:07:16,726 --> 00:07:18,395 TO CLINICAL CARDIOVASCULAR 212 00:07:18,395 --> 00:07:21,331 DISEASE. 213 00:07:21,331 --> 00:07:22,866 ONE OF THE LARGEST AND BEST 214 00:07:22,866 --> 00:07:24,033 STUDIES IN THE LAST SEVERAL 215 00:07:24,033 --> 00:07:25,568 YEARS THAT HAS LOOKED AT THE 216 00:07:25,568 --> 00:07:27,537 ASSOCIATION OF ADVERSE PREGNANCY 217 00:07:27,537 --> 00:07:30,073 OUTCOMES AND LIFETIME RISK OF 218 00:07:30,073 --> 00:07:30,940 CARDIOVASCULAR DISEASE IS SHOWN 219 00:07:30,940 --> 00:07:31,908 HERE. 220 00:07:31,908 --> 00:07:34,544 THIS STUDY THAT INCLUDED OVER 221 00:07:34,544 --> 00:07:35,645 2 MILLION SWEDISH INDIVIDUALS 222 00:07:35,645 --> 00:07:39,382 WHO HAD HAD PREGNANCIES BETWEEN 223 00:07:39,382 --> 00:07:42,652 1970 TO 2000 WERE FOLLOWED FOR A 224 00:07:42,652 --> 00:07:44,487 MEDIAN OF AT LEAST 25 YEARS WITH 225 00:07:44,487 --> 00:07:49,192 A MAXIMUM OF 46 YEARS AT AGE 27 226 00:07:49,192 --> 00:07:50,760 AT FIRST DELIVERY, WERE THEN 227 00:07:50,760 --> 00:07:53,129 EVALUATED FOR THEIR RISK OF 228 00:07:53,129 --> 00:07:53,630 ISCHEMIC HEART DISEASE. 229 00:07:53,630 --> 00:07:54,898 AS YOU CAN SEE IN THIS FIGURE, 230 00:07:54,898 --> 00:07:58,168 THE RISK ASSOCIATED WITH EACH 231 00:07:58,168 --> 00:08:01,371 APO IS INCREASED FOR THE RISK OF 232 00:08:01,371 --> 00:08:02,005 CVD. 233 00:08:02,005 --> 00:08:03,773 NOW WE SEE DIFFERENT PATTERNS 234 00:08:03,773 --> 00:08:04,741 ACROSS ADVERSE PREGNANCY 235 00:08:04,741 --> 00:08:05,608 OUTCOMES WITH SOME OF THE 236 00:08:05,608 --> 00:08:07,410 HIGHEST RISK RELATED TO 237 00:08:07,410 --> 00:08:08,378 PREECLAMPSIA, BUT CONSISTENT 238 00:08:08,378 --> 00:08:12,182 PATTERNS THROUGHOUT. 239 00:08:12,182 --> 00:08:13,850 ONE OF THE THINGS THAT WAS 240 00:08:13,850 --> 00:08:15,652 REALLY INTERESTING ABOUT THIS 241 00:08:15,652 --> 00:08:17,086 ANALYSIS WAS THAT THEY ALSO 242 00:08:17,086 --> 00:08:18,054 LOOKED AT THE INDIVIDUALS WHO 243 00:08:18,054 --> 00:08:19,923 HAD MULTIPLE ADVERSE PREGNANCY 244 00:08:19,923 --> 00:08:21,691 OUTCOMES AND DEMONSTRATED THIS 245 00:08:21,691 --> 00:08:24,327 ADDITIVE EFFECT, SO IF YOU HAD 246 00:08:24,327 --> 00:08:26,095 PRETERM AND PREECLAMPSIA OR 247 00:08:26,095 --> 00:08:27,397 PRETERM AND GESTATIONAL 248 00:08:27,397 --> 00:08:29,032 DIABETES, YOU HAD AN EVEN HIGHER 249 00:08:29,032 --> 00:08:31,668 RISK OF ISCHEMIC HEART DISEASE 250 00:08:31,668 --> 00:08:33,169 IN FOLLOW-UP AND WHAT'S EVEN 251 00:08:33,169 --> 00:08:34,304 MORE IMPORTANT IS THAT ABOUT A 252 00:08:34,304 --> 00:08:36,773 THIRD OF PEOPLE HAD AT LEAST ONE 253 00:08:36,773 --> 00:08:37,774 ADVERSE PREGNANCY OUT COME, SO 254 00:08:37,774 --> 00:08:39,209 THIS IS A PREVALENT COMPLICATION 255 00:08:39,209 --> 00:08:41,711 THAT IS ASSOCIATED WITH UP TO A 256 00:08:41,711 --> 00:08:43,480 TWOFOLD RISK OF CARDIOVASCULAR 257 00:08:43,480 --> 00:08:47,717 DISEASE ACROSS THE LIFE COURSE. 258 00:08:47,717 --> 00:08:50,253 SO IF WE WANT TO THINK ABOUT 259 00:08:50,253 --> 00:08:51,955 THAT STRUCTURE OF ADVERSE 260 00:08:51,955 --> 00:08:53,223 PREGNANCY OUT COME GOING TO 261 00:08:53,223 --> 00:08:54,691 CARDIOVASCULAR DISEASE, I THINK 262 00:08:54,691 --> 00:08:56,025 IT'S HELPFUL TO THINK ABOUT THE 263 00:08:56,025 --> 00:08:57,126 PATHWAYS THROUGH WHICH THIS MAY 264 00:08:57,126 --> 00:08:58,428 OCCUR, WHERE WE HAVE DATA AND 265 00:08:58,428 --> 00:09:00,296 WHERE WE MAY NEED MORE DATA TO 266 00:09:00,296 --> 00:09:02,365 UNDERSTAND WHERE WE COULD MODIFY 267 00:09:02,365 --> 00:09:03,900 AND TARGET TO REALLY OPTIMIZE 268 00:09:03,900 --> 00:09:06,302 PREVENTION. 269 00:09:06,302 --> 00:09:08,271 SO LET'S FIRST START WITH 270 00:09:08,271 --> 00:09:09,172 TRADITIONAL CARDIOVASCULAR 271 00:09:09,172 --> 00:09:13,209 DISEASE RISK FACTORS. 272 00:09:13,209 --> 00:09:15,178 DATA FROM THE NURSES HEALTH 273 00:09:15,178 --> 00:09:16,713 2 STUDY ARE AMONG SOME OF THE 274 00:09:16,713 --> 00:09:19,449 LARGEST SAMPLE WHERE WE HAVE 275 00:09:19,449 --> 00:09:20,550 INDIVIDUALS WHO ARE FOLLOWED 276 00:09:20,550 --> 00:09:23,653 FROM THEIR FIRST BIRTH TO 277 00:09:23,653 --> 00:09:25,788 INCIDENCE OF CARDIOVASCULAR 278 00:09:25,788 --> 00:09:28,057 DISEASE OVER A FOLLOW-UP OF MORE 279 00:09:28,057 --> 00:09:28,658 THAN 40 YEARS. 280 00:09:28,658 --> 00:09:30,927 SHOWN IN THIS TABLE IS THE 281 00:09:30,927 --> 00:09:32,328 PROPORTION MEDIATED FOR 282 00:09:32,328 --> 00:09:35,198 TRADITIONAL RISK FACTORS AFTER 283 00:09:35,198 --> 00:09:36,499 AN INCIDENT HYPERTENSIVE 284 00:09:36,499 --> 00:09:38,034 DISORDER OF PREGNANCY, 285 00:09:38,034 --> 00:09:40,670 SPECIFICALLY HYPERTENSION, 286 00:09:40,670 --> 00:09:41,638 HYPERLIPIDEMIA, DIABETES, AND 287 00:09:41,638 --> 00:09:47,377 CHANGE IN BMI. 288 00:09:47,377 --> 00:09:49,579 WHAT'S REALLY STRIKING IS 84% OF 289 00:09:49,579 --> 00:09:50,713 THE ASSOCIATION BETWEEN 290 00:09:50,713 --> 00:09:51,981 GESTATIONAL HYPERTENSION AND 57% 291 00:09:51,981 --> 00:09:53,449 OF THE ASSOCIATION BETWEEN 292 00:09:53,449 --> 00:09:55,652 PREECLAMPSIA AND FOLLOW-UP CVD 293 00:09:55,652 --> 00:09:58,288 IS MEDIATED BY THESE TRADITIONAL 294 00:09:58,288 --> 00:10:00,456 RISK FACTORS, SO TARGETS THAT WE 295 00:10:00,456 --> 00:10:02,125 COMMONLY THINK ABOUT AFTER 296 00:10:02,125 --> 00:10:03,860 HYPERTENSIVE DISORDERS OF 297 00:10:03,860 --> 00:10:05,161 PREGNANCY MEDIATE THE MAJORITY 298 00:10:05,161 --> 00:10:07,730 OF THE RISK FOR CARDIOVASCULAR 299 00:10:07,730 --> 00:10:09,332 DISEASE AND HIGHLIGHT KEY 300 00:10:09,332 --> 00:10:11,167 TARGETS ONCE SOMEONE HAS BEEN 301 00:10:11,167 --> 00:10:12,569 IDENTIFIED WITH ELEVATED BLOOD 302 00:10:12,569 --> 00:10:14,771 PRESSURE DURING PREGNANCY. 303 00:10:14,771 --> 00:10:15,538 NOW WHAT'S IMPORTANT IS THAT 304 00:10:15,538 --> 00:10:18,074 THESE ARE IMPORTANT FACTORS OR 305 00:10:18,074 --> 00:10:19,108 TARGETS WHETHER OR NOT SOMEONE 306 00:10:19,108 --> 00:10:21,244 GOES ON TO HAVE CHRONIC 307 00:10:21,244 --> 00:10:22,645 HYPERTENSION, TO JUST HAVING 308 00:10:22,645 --> 00:10:23,513 ELEVATED BLOOD PRESSURE IN 309 00:10:23,513 --> 00:10:25,682 PREGNANCY ITSELF THAT IS 310 00:10:25,682 --> 00:10:27,150 ASSOCIATED WITH FUTURE 311 00:10:27,150 --> 00:10:28,451 CARDIOVASCULAR DISEASE RISK WHEN 312 00:10:28,451 --> 00:10:30,887 DEFINED AS HYPERTENSIVE DISORDER 313 00:10:30,887 --> 00:10:35,325 OF PREGNANCY. 314 00:10:35,325 --> 00:10:36,659 THE NEXT PATHWAY THAT WE'LL TALK 315 00:10:36,659 --> 00:10:38,428 ABOUT IS ABNORMAL CARDIAC 316 00:10:38,428 --> 00:10:38,995 MECHANICS. 317 00:10:38,995 --> 00:10:41,664 WE ALSO KNOW THAT WHEN WE THINK 318 00:10:41,664 --> 00:10:44,400 ABOUT CARDIOVASCULAR DISEASE 319 00:10:44,400 --> 00:10:46,603 BROADLY, HEART FAILURE CAN BE A 320 00:10:46,603 --> 00:10:47,270 COMPLICATION FOLLOWING ADVERSE 321 00:10:47,270 --> 00:10:47,804 PREGNANCY OUTCOMES. 322 00:10:47,804 --> 00:10:49,238 WHILE WE HAVE LESS DATA HERE, 323 00:10:49,238 --> 00:10:51,074 THIS IS A REALLY INTERESTING 324 00:10:51,074 --> 00:10:52,842 SINGLE CENTER STUDY THAT LOOKED 325 00:10:52,842 --> 00:10:56,312 AT ABOUT 130 WOMEN WHO WERE 8 TO 326 00:10:56,312 --> 00:10:58,314 10 YEARS AFTER DELIVERY, WHO HAD 327 00:10:58,314 --> 00:10:59,616 EXPERIENCED A HYPERTENSIVE 328 00:10:59,616 --> 00:11:02,685 DISORDER OF PREGNANCY, AND 329 00:11:02,685 --> 00:11:03,886 EXAMINED ECHO CARDIOGRAPHIC 330 00:11:03,886 --> 00:11:05,855 EVIDENCE OF SEPTAL WALL 331 00:11:05,855 --> 00:11:07,590 THICKNESS, LV WALL REMODELING 332 00:11:07,590 --> 00:11:09,158 AND MITRAL INFLOW TO LOOK AT 333 00:11:09,158 --> 00:11:10,893 PATTERNS OF ADVERSE CARDIAC 334 00:11:10,893 --> 00:11:11,327 REMODELING. 335 00:11:11,327 --> 00:11:14,297 NOW IMPORTANTLY, OF THEIR 336 00:11:14,297 --> 00:11:15,865 SAMPLE, 23% HAD HYPERTENSIVE 337 00:11:15,865 --> 00:11:18,768 DISORDERS OF PREGNANCY AND A 338 00:11:18,768 --> 00:11:20,837 MUCH GREATER PROPORTION OF 339 00:11:20,837 --> 00:11:23,906 INDIVIDUALS, 63% VERSUS 26%, HAD 340 00:11:23,906 --> 00:11:25,108 HYPERTENSION POST-DELIVERY WHO 341 00:11:25,108 --> 00:11:26,876 HAD HAD HYPERTENSIVE DISORDERS. 342 00:11:26,876 --> 00:11:28,378 SO THERE WAS AN ADDITIVE EFFECT 343 00:11:28,378 --> 00:11:30,146 WHERE PEOPLE WHO HAD HAD 344 00:11:30,146 --> 00:11:31,447 HYPERTENSIVE DISORDERS OF 345 00:11:31,447 --> 00:11:33,416 PREGNANCY AND HYPERTENSION HAD 346 00:11:33,416 --> 00:11:37,053 THE MOST ADVERSE REMODELING IN 347 00:11:37,053 --> 00:11:40,323 THEIR LEFT VENTRICLE. 348 00:11:40,323 --> 00:11:41,524 ONE OF THE THINGS THAT THIS 349 00:11:41,524 --> 00:11:43,159 STUDY RELY HIGHLIGHTED IS THAT 350 00:11:43,159 --> 00:11:44,927 THESE ADVERSE CHANGES THAT WERE 351 00:11:44,927 --> 00:11:46,763 OBSERVED 8 TO 10 YEARS AFTER 352 00:11:46,763 --> 00:11:49,599 PREGNANCY MAY HAVE BEEN 353 00:11:49,599 --> 00:11:51,034 MANIFESTATIONS OF 354 00:11:51,034 --> 00:11:52,068 PATHOPHYSIOLOGIC RESPONSES 355 00:11:52,068 --> 00:11:53,970 RELATED TO PREGNANCY ITSELF, 356 00:11:53,970 --> 00:11:56,806 ESPECIALLY AMONG THOSE WHO HAD 357 00:11:56,806 --> 00:11:57,507 HYPERTENSIVE DISORDERS. 358 00:11:57,507 --> 00:11:59,642 THIS DIAGRAM HIGHLIGHTS THE 359 00:11:59,642 --> 00:12:01,444 IMPORTANCE OF THE LEFT 360 00:12:01,444 --> 00:12:02,645 VENTRICLE'S ADAPTATION TO 361 00:12:02,645 --> 00:12:04,480 PREGNANCY THAT MAY ACTUALLY BE 362 00:12:04,480 --> 00:12:06,582 INFLUENCED BY PRE-EXISTING 363 00:12:06,582 --> 00:12:07,216 CARDIOVASCULAR DISEASE ORIS 364 00:12:07,216 --> 00:12:07,784 BEING. 365 00:12:07,784 --> 00:12:09,419 AND WE'LL TALK A LITTLE BIT MORE 366 00:12:09,419 --> 00:12:11,020 ABOUT THIS IN THE FOLLOWING 367 00:12:11,020 --> 00:12:13,022 SLIDES, BUT THE IDEA THAT 368 00:12:13,022 --> 00:12:14,891 POTENTIALLY SOME OF THE ADVERSE 369 00:12:14,891 --> 00:12:16,726 LV REMODELING MAY HAVE ALREADY 370 00:12:16,726 --> 00:12:18,361 BEEN PRESENT BEFORE THE 371 00:12:18,361 --> 00:12:19,462 PREGNANCY IS A QUESTION THAT 372 00:12:19,462 --> 00:12:24,567 REMAINS UNANSWERED. 373 00:12:24,567 --> 00:12:25,501 SO LET'S TALK ABOUT THE 374 00:12:25,501 --> 00:12:29,872 MECHANISM AND PATHWAY TO@THROW 375 00:12:29,872 --> 00:12:30,940 SCLEROSIS OR HEART DISEASE THAT 376 00:12:30,940 --> 00:12:33,476 IS SUBCLINICAL@THROW SCLEROSIS. 377 00:12:33,476 --> 00:12:34,911 ONE OF THE LARGEST STUDIES THAT 378 00:12:34,911 --> 00:12:36,345 WAS RECENTLY PUBLISHED COMES 379 00:12:36,345 --> 00:12:39,148 FROM THE SWEDISH CARDIOPULMONARY 380 00:12:39,148 --> 00:12:39,615 BIOIMAGE STUDY. 381 00:12:39,615 --> 00:12:41,584 THIS STUDY HAD ABOUT 10,000 382 00:12:41,584 --> 00:12:44,554 INDIVIDUALS WHO WERE 50 TO 65 383 00:12:44,554 --> 00:12:47,156 YEARS WHO HAD HAD A PRIOR BIRTH 384 00:12:47,156 --> 00:12:49,559 WITHIN THE SWEDISH SYSTEM. 385 00:12:49,559 --> 00:12:51,861 ABOUT 19% HAD AN ADVERSE 386 00:12:51,861 --> 00:12:55,565 PREGNANCY OUT COME AND THEN WERE 387 00:12:55,565 --> 00:12:59,402 EXAMINED WITH A CORONARY CTA. 388 00:12:59,402 --> 00:13:00,937 THE INNOVATIVE PIECE ABOUT THIS 389 00:13:00,937 --> 00:13:02,572 STUDY IS THAT THEY LOOKED NOT 390 00:13:02,572 --> 00:13:06,075 JUST AT CORONARY CALCIUM, BUT 391 00:13:06,075 --> 00:13:08,611 ALSO AT NON-CALCIFIED PLAQUE 392 00:13:08,611 --> 00:13:10,646 WITH CTA. 393 00:13:10,646 --> 00:13:12,815 PARTICULARLY AMONG YOUNG WOMEN, 394 00:13:12,815 --> 00:13:14,584 BEFORE ANY CALCIFIED PLAQUE IS 395 00:13:14,584 --> 00:13:19,622 PRESENT, ANY CORONARY 396 00:13:19,622 --> 00:13:20,523 ATHEROSCLEROSIS WAS PRESENT AND 397 00:13:20,523 --> 00:13:21,624 THAT'S SPECIFICALLY WHAT THEY 398 00:13:21,624 --> 00:13:22,358 SAW. 399 00:13:22,358 --> 00:13:23,159 SPECIFICALLY AMONG INDIVIDUALS 400 00:13:23,159 --> 00:13:24,994 WHO HAD ADVERSE PREGNANCY OUT 401 00:13:24,994 --> 00:13:31,234 COME, 32% HAD ANY. 402 00:13:31,234 --> 00:13:33,102 IF WE LOOK ACROSS THE VARIOUS 403 00:13:33,102 --> 00:13:37,240 OUTCOMES THAT WERE OBSERVED, ANY 404 00:13:37,240 --> 00:13:39,142 STENOSIS, ANY CALCIFIED PLAQUE 405 00:13:39,142 --> 00:13:40,510 OR SCORE GREATER THAN 100, WE 406 00:13:40,510 --> 00:13:42,278 SEE A CONSISTENT PATTERN OF 407 00:13:42,278 --> 00:13:45,114 HIGHER BURDEN OF 408 00:13:45,114 --> 00:13:46,315 CORONARY@SCLEROSIS OR 409 00:13:46,315 --> 00:13:47,517 SUBCLINICAL AMONG THOSE WHO 410 00:13:47,517 --> 00:13:48,818 EXPERIENCE AN ADVERSE PREGNANCY 411 00:13:48,818 --> 00:13:51,988 OUT COME. 412 00:13:51,988 --> 00:13:53,089 SO IF WE THOUGHT ABOUT THE 413 00:13:53,089 --> 00:13:55,625 DIFFERENT PATHWAYS FROM 414 00:13:55,625 --> 00:13:57,794 SUBCLINICAL CVD TO CLINICAL CVD, 415 00:13:57,794 --> 00:14:00,263 WE HAVE TO ALSO ASK ABOUT WHAT 416 00:14:00,263 --> 00:14:02,298 ARE THE ANTECEDENTS TO BOTH 417 00:14:02,298 --> 00:14:04,467 ADVERSE PREGNANCY OUTCOMES AND 418 00:14:04,467 --> 00:14:06,669 CVD THAT MAY HELP US IDENTIFY 419 00:14:06,669 --> 00:14:09,939 EARLIER PREVENTION STRATEGIES. 420 00:14:09,939 --> 00:14:11,841 IF WE THINK ABOUT THE SHARED 421 00:14:11,841 --> 00:14:13,342 ANTECEDENT PATHWAYS, THERE ARE 422 00:14:13,342 --> 00:14:15,511 TRADITIONAL RISK FACTORS LIKE 423 00:14:15,511 --> 00:14:17,046 OBESITY, SEDENTARY BEHAVIOR, 424 00:14:17,046 --> 00:14:19,816 POOR QUALITY DIET, PRE-EXISTING 425 00:14:19,816 --> 00:14:21,317 HYPERTENSION, HYPERLIPIDEMIA OR 426 00:14:21,317 --> 00:14:23,619 DIABETES, AS WELL AS PREGNANCY 427 00:14:23,619 --> 00:14:25,154 OR RELATED RISK FACTORS UNIQUE 428 00:14:25,154 --> 00:14:27,456 OH A BIRTHING INDIVIDUAL THAT 429 00:14:27,456 --> 00:14:29,192 MAY INCLUDE VASCULAR AND 430 00:14:29,192 --> 00:14:31,160 PLACENTAL DYSFUNCTION OR GENETIC 431 00:14:31,160 --> 00:14:31,928 PREDISPOSITION TO ADVERSE 432 00:14:31,928 --> 00:14:34,597 PREGNANCY OUTCOMES THAT LEAD TO 433 00:14:34,597 --> 00:14:37,967 THIS PATH OF CVD. 434 00:14:37,967 --> 00:14:38,601 BUT ONE OF THE KEY QUESTIONS 435 00:14:38,601 --> 00:14:40,303 THAT REMAINS UNANSWERED IS 436 00:14:40,303 --> 00:14:41,871 WHETHER OR NOT THE ADVERSE 437 00:14:41,871 --> 00:14:43,306 PREGNANCY OUT COME ITSELF IS A 438 00:14:43,306 --> 00:14:48,244 MARKER OR MEDIATOR OF FUTURE 439 00:14:48,244 --> 00:14:49,212 CARDIOVASCULAR DISEASE RISK. 440 00:14:49,212 --> 00:14:50,313 THIS SCHEMATIC ORIGINALLY 441 00:14:50,313 --> 00:14:52,281 PUBLISHED OVER 20 YEARS 442 00:14:52,281 --> 00:14:53,149 HIGHLIGHTS TWO DIFFERENT 443 00:14:53,149 --> 00:14:54,150 TRAJECTORIES IN A BIRTHING 444 00:14:54,150 --> 00:14:54,584 INDIVIDUAL. 445 00:14:54,584 --> 00:14:56,953 ONE BY WHICH THE INDIVIDUAL HAS 446 00:14:56,953 --> 00:15:01,123 TWO PREGNANCIES WITH AN ADVERSE 447 00:15:01,123 --> 00:15:02,658 PREGNANCY OUTCOME, AND ONE BY 448 00:15:02,658 --> 00:15:03,960 WHICH AN INDIVIDUAL HAS A 449 00:15:03,960 --> 00:15:04,727 HEALTHY PREGNANCY. 450 00:15:04,727 --> 00:15:07,263 YOU CAN SEE THE QUESTION HERE IS 451 00:15:07,263 --> 00:15:09,565 THAT WHETHER OR NOT THESE TWO 452 00:15:09,565 --> 00:15:10,366 INDIVIDUALS MEET THE THRESHOLD 453 00:15:10,366 --> 00:15:12,168 FOR DEVELOPING VASCULAR RISK, 454 00:15:12,168 --> 00:15:13,636 WHETHER THAT'S CARDIOVASCULAR 455 00:15:13,636 --> 00:15:16,005 DISEASE OR HYPERTENSION, REALLY 456 00:15:16,005 --> 00:15:17,907 DEPENDS ON THEIR STARTING POINT 457 00:15:17,907 --> 00:15:19,976 AS WELL AS THE INJURY RELATED TO 458 00:15:19,976 --> 00:15:21,577 PREGNANCY. 459 00:15:21,577 --> 00:15:23,679 SO THE FUNDAMENTAL QUESTION 460 00:15:23,679 --> 00:15:24,881 REMAINS, IS AN INDIVIDUAL WHO 461 00:15:24,881 --> 00:15:26,649 HAS AN ADVERSE PREGNANCY OUT 462 00:15:26,649 --> 00:15:30,019 COME REALLY UNMASKED IN THIS 463 00:15:30,019 --> 00:15:31,220 LATENT RISK THAT ALREADY EXISTED 464 00:15:31,220 --> 00:15:33,089 AND THEY CONTINUE ON THEIR 465 00:15:33,089 --> 00:15:34,290 TRAJECTORY THEY WERE ALREADY ON 466 00:15:34,290 --> 00:15:35,925 OR IS THERE SOMETHING ABOUT THE 467 00:15:35,925 --> 00:15:37,126 ADVERSE PREGNANCY OUT COME THAT 468 00:15:37,126 --> 00:15:38,527 ALTERS THEIR TRAJECTORY AND 469 00:15:38,527 --> 00:15:40,296 LEADS THEM INTO A HIGHER RISK 470 00:15:40,296 --> 00:15:43,266 CATEGORY? 471 00:15:43,266 --> 00:15:45,668 SO SHOWN HERE IN A CAUSAL 472 00:15:45,668 --> 00:15:47,069 STRUCTURE DIAGRAM, WE REALLY 473 00:15:47,069 --> 00:15:50,439 WANTED TO ASK THIS QUESTION OF 474 00:15:50,439 --> 00:15:51,674 IF ADVERSE PREGNANCY OUTCOMES 475 00:15:51,674 --> 00:15:54,176 ARE A MARKER OR MEDIATOR BASED 476 00:15:54,176 --> 00:15:56,946 ON WHERE SOMEONE BEGINS THEIR 477 00:15:56,946 --> 00:15:57,914 PREPREGNANCY CARDIOMETABOLIC 478 00:15:57,914 --> 00:15:59,415 HEALTH, WHAT THEIR 479 00:15:59,415 --> 00:16:00,316 CARDIOMETABOLIC HEALTH MAY BE 480 00:16:00,316 --> 00:16:01,384 AFTER PREGNANCY, AND WHAT THAT 481 00:16:01,384 --> 00:16:03,719 MEANS FOR THEIR RISK FOR 482 00:16:03,719 --> 00:16:04,353 CARDIOVASCULAR DISEASE, GIVEN 483 00:16:04,353 --> 00:16:06,522 THAT EACH OF THESE INDEPENDENT 484 00:16:06,522 --> 00:16:08,190 PATHWAYS MAY BE LEADING TO 485 00:16:08,190 --> 00:16:09,258 HIGHER CARDIOVASCULAR DISEASE 486 00:16:09,258 --> 00:16:11,260 RISK. 487 00:16:11,260 --> 00:16:12,395 SAID ANOTHER WAY, THIS ANALOGY 488 00:16:12,395 --> 00:16:14,330 OF THIS PICTURE SHOWN HERE ARE 489 00:16:14,330 --> 00:16:15,631 ADVERSE PREGNANCY OUTCOMES 490 00:16:15,631 --> 00:16:17,633 REALLY THE SMOKE DETECTOR 491 00:16:17,633 --> 00:16:18,935 HIGHLIGHTING THE RISK THAT 492 00:16:18,935 --> 00:16:20,336 ALREADY EXISTS WHEN THERE'S A 493 00:16:20,336 --> 00:16:23,940 FIRE IN THE HOUSE. 494 00:16:23,940 --> 00:16:24,941 SO HOW CAN WE START TO 495 00:16:24,941 --> 00:16:25,942 UNDERSTAND THIS? 496 00:16:25,942 --> 00:16:28,444 IN WORK FUNDED BY THE NHLBI IN 497 00:16:28,444 --> 00:16:30,513 THE NEW MOM TO BE HEART HEALTH 498 00:16:30,513 --> 00:16:34,283 STUDY, WHICH IS A COHORT OF 499 00:16:34,283 --> 00:16:35,217 INDIVIDUALS RECRUITED IN THE 500 00:16:35,217 --> 00:16:37,186 BEGINNING OF THEIR FIRST 501 00:16:37,186 --> 00:16:39,155 PREGNANCY, SO WE HAD EARLY 502 00:16:39,155 --> 00:16:41,290 MEASURES OF BMI EARLY IN THE 503 00:16:41,290 --> 00:16:44,327 FIRST TRIMESTER, AND WERE THEN 504 00:16:44,327 --> 00:16:45,628 FOLLOWED DURING THIS PREGNANCY 505 00:16:45,628 --> 00:16:47,797 AND NOW HAVE BEEN FOLLOWED FOR 506 00:16:47,797 --> 00:16:50,333 ABOUT 10 YEARS POSTPARTUM. 507 00:16:50,333 --> 00:16:52,802 AT 2 TO 7 YEARS DURING FOLLOW-UP 508 00:16:52,802 --> 00:16:54,603 POSTPARTUM RISK FACTORS WERE 509 00:16:54,603 --> 00:16:56,339 MEASURED AND ALLOWED US TO 510 00:16:56,339 --> 00:16:59,075 STRUCTURE OUR QUESTION OF 511 00:16:59,075 --> 00:17:01,243 INTEREST WITH THIS SHOWN HERE, 512 00:17:01,243 --> 00:17:03,346 PREPREGNANCY OR EARLY PREGNANCY 513 00:17:03,346 --> 00:17:04,647 BMI ASSOCIATE WITH ADVERSE 514 00:17:04,647 --> 00:17:06,849 PREGNANCY OUTCOMES AS WELL AS 515 00:17:06,849 --> 00:17:07,616 POSTPARTUM CARDIOVASCULAR 516 00:17:07,616 --> 00:17:08,951 DISEASE RISK FACTORS, AND WHAT 517 00:17:08,951 --> 00:17:11,187 PROPORTION OF THAT IS MEDIATED 518 00:17:11,187 --> 00:17:14,056 IF ANY BY ADVERSE PREGNANCY 519 00:17:14,056 --> 00:17:15,825 OUTCOMES? 520 00:17:15,825 --> 00:17:18,327 SO IF WE'LL BREAK DOWN THE 521 00:17:18,327 --> 00:17:19,328 EFFECT OR ASSOCIATIONS WE'LL 522 00:17:19,328 --> 00:17:20,997 LOOK AT THE TOTAL EFFECTIVENESS 523 00:17:20,997 --> 00:17:22,264 ANALYSIS LOOKING AT THE 524 00:17:22,264 --> 00:17:25,668 PREPREGNANCY BMI AND POSTPARTUM 525 00:17:25,668 --> 00:17:26,969 CVD RIS FACTORS. 526 00:17:26,969 --> 00:17:28,204 WE BROKE THAT DOWN INTO THE 527 00:17:28,204 --> 00:17:29,705 DIRECT AND INDIRECT EFFECT TO 528 00:17:29,705 --> 00:17:37,113 GET AT THE PROPORTION MEDIATED. 529 00:17:37,113 --> 00:17:40,716 IF WE LOOK HERE AT THE TOTAL 530 00:17:40,716 --> 00:17:43,119 EFFECT, THE UNADJUSTED AND 531 00:17:43,119 --> 00:17:47,156 ADJUSTED BETA COEFFICIENT 532 00:17:47,156 --> 00:17:49,558 SHOW -- AND HYPERTENSION AND 533 00:17:49,558 --> 00:17:51,327 HYPERLIPIDEMIA IN THE FOLLOW-UP 534 00:17:51,327 --> 00:17:53,963 POSTPARTUM PERIOD. 535 00:17:53,963 --> 00:17:55,131 HOWEVER, WHEN WE ACCOUNT FOR THE 536 00:17:55,131 --> 00:17:56,932 RISK FACTORS COMING IN TO 537 00:17:56,932 --> 00:17:58,667 PREGNANCY, AND WE EXAMINE THE 538 00:17:58,667 --> 00:18:00,870 PROPORTION MEDIATED, ONLY A 539 00:18:00,870 --> 00:18:03,039 SMALL PROPORTION, LESS THAN 20% 540 00:18:03,039 --> 00:18:05,141 OF THAT, IS MEDIATED BY THE 541 00:18:05,141 --> 00:18:06,542 HYPERTENSIVE DISORDER OF 542 00:18:06,542 --> 00:18:08,110 PREGNANCY FOR HYPERTENSION AND 543 00:18:08,110 --> 00:18:10,146 THERE'S NO MEDIATION WITH 544 00:18:10,146 --> 00:18:11,580 HYPERLIPIDEMIA. 545 00:18:11,580 --> 00:18:13,416 THIS HIGHLIGHTS THE IMPORTANCE 546 00:18:13,416 --> 00:18:14,984 OF ADVERSE PREGNANCY OUTCOMES AS 547 00:18:14,984 --> 00:18:17,920 A MARKER AND NOT A MEDIATOR OF 548 00:18:17,920 --> 00:18:19,789 THE ASSOCIATION WITH 549 00:18:19,789 --> 00:18:20,623 CARDIOVASCULAR DISEASE RISK. 550 00:18:20,623 --> 00:18:22,925 NOW THESE WERE EARLY OUTCOMES IN 551 00:18:22,925 --> 00:18:24,160 THE SHORT TERM AND FUTURE 552 00:18:24,160 --> 00:18:25,461 FOLLOW-UP STUDIES ARE STILL 553 00:18:25,461 --> 00:18:26,996 NEEDED INCLUDING IN THIS COHORT 554 00:18:26,996 --> 00:18:33,135 AND OTHERS. 555 00:18:33,135 --> 00:18:34,336 SO LET'S MOVE ON TO THE NEXT 556 00:18:34,336 --> 00:18:35,404 QUESTION, WHAT IS THE 557 00:18:35,404 --> 00:18:36,272 EPIDEMIOLOGY OF ADVERSE 558 00:18:36,272 --> 00:18:38,574 PREGNANCY OUTCOMES AND POTENTIAL 559 00:18:38,574 --> 00:18:39,575 DRIVERS, WHAT DOES THE BURDEN 560 00:18:39,575 --> 00:18:40,576 LOOK LIKE IN THE U.S. 561 00:18:40,576 --> 00:18:42,411 POPULATION? 562 00:18:42,411 --> 00:18:45,047 SO IF WE ZERO IN ON THE 563 00:18:45,047 --> 00:18:46,449 SHORT-TERM PERIOD HERE IN THE 564 00:18:46,449 --> 00:18:48,317 MIDDLE OF THIS CONCEPTUAL FIGURE 565 00:18:48,317 --> 00:18:51,587 WE'VE BEEN USING, AS MANY OF YOU 566 00:18:51,587 --> 00:18:53,789 ARE AWARE, CARDIOVASCULAR 567 00:18:53,789 --> 00:18:56,525 DISEASE IS A LEADING CAUSE OF 568 00:18:56,525 --> 00:18:58,594 MATERNAL DEATHS AND THE MATERNAL 569 00:18:58,594 --> 00:19:02,665 MORTALITY RATIO IN THE IN 2018 570 00:19:02,665 --> 00:19:04,533 IMAIRED OTHER HIGH-INCOME 571 00:19:04,533 --> 00:19:05,601 COUNTRIES WHICH HAS 572 00:19:05,601 --> 00:19:07,403 UNFORTUNATELY ONLY INCREASED 573 00:19:07,403 --> 00:19:09,672 SINCE THEN IS MUCH HIGHER THAN 574 00:19:09,672 --> 00:19:10,439 OTHER HIGH-INCOME COUNTRIES. 575 00:19:10,439 --> 00:19:11,740 FURTHER, GREATER THAN 80% OF 576 00:19:11,740 --> 00:19:13,509 THESE DEATHS ARE PREVENTIBLE, 577 00:19:13,509 --> 00:19:14,743 WHICH WITH CARDIOVASCULAR 578 00:19:14,743 --> 00:19:19,849 DISEASE BEING A LEADING CAUSE. 579 00:19:19,849 --> 00:19:22,151 ONE OF THE THINGS THAT IS REALLY 580 00:19:22,151 --> 00:19:25,988 STRIKING IS THAT A LOT OF THESE 581 00:19:25,988 --> 00:19:27,056 PREGNANCY-RELATED DEATHS OCCUR 582 00:19:27,056 --> 00:19:29,091 IN THE POSTPARTUM PERIOD, SO 583 00:19:29,091 --> 00:19:31,360 MORE THAN TWO THIRDS OF DEATHS 584 00:19:31,360 --> 00:19:34,396 ARE OCCURRING IN THE PERIOD 585 00:19:34,396 --> 00:19:37,466 AFTER PREGNANCY, PARTICULARLY IN 586 00:19:37,466 --> 00:19:39,768 THAT 43 TO 365 DAY POSTPARTUM 587 00:19:39,768 --> 00:19:41,871 PERIOD WHEN MANY PEOPLE MAY NOT 588 00:19:41,871 --> 00:19:43,506 EVEN CONSIDER THEMSELVES 589 00:19:43,506 --> 00:19:44,907 POSTPARTUM ANYMORE, BUT 590 00:19:44,907 --> 00:19:46,442 PARTICULARLY THOSE 591 00:19:46,442 --> 00:19:47,309 CARDIOVASCULAR CONTRIBUTIONS 592 00:19:47,309 --> 00:19:50,479 RELATED TO HYPERTENSION, STROKE, 593 00:19:50,479 --> 00:19:51,914 CARDIOMYOPATHY, MAY STILL BE A 594 00:19:51,914 --> 00:19:56,919 PROMINENT CAUSE OF THESE DEATHS. 595 00:19:56,919 --> 00:19:58,354 IF WE LOOK AT THIS IN A 596 00:19:58,354 --> 00:19:59,755 DIFFERENT WAY, THE ABSOLUTE 597 00:19:59,755 --> 00:20:02,024 BURDEN, WHAT ARE THE COUNTS IN 598 00:20:02,024 --> 00:20:03,993 2019 IN THE PRECOVID ERA TO GET 599 00:20:03,993 --> 00:20:05,027 A SENSE OF THIS? 600 00:20:05,027 --> 00:20:07,596 WELL, THERE'S NEARLY 300,000 601 00:20:07,596 --> 00:20:09,198 LIVE BIRTHS THAT ARE COMPLICATED 602 00:20:09,198 --> 00:20:11,367 BY HYPERTENSIVE DISORDERS, ABOUT 603 00:20:11,367 --> 00:20:13,936 50,000 WITH MATERNAL MORBIDITY, 604 00:20:13,936 --> 00:20:16,405 10,000 WITH ECLAMPSIA, AND A 605 00:20:16,405 --> 00:20:18,240 SUBSTANTIAL NUMBER, OVER 6,000 606 00:20:18,240 --> 00:20:20,209 REQUIRE ADMISSION TO AN ICU 607 00:20:20,209 --> 00:20:23,846 DURING THE PREGNANCY OR DELIVERY 608 00:20:23,846 --> 00:20:26,415 HOSPITALIZATION, AND ABOUT 754 609 00:20:26,415 --> 00:20:34,790 MATERNAL DEATHS. 610 00:20:34,790 --> 00:20:37,860 IF WE LOOK OVER TIME WE SEE 611 00:20:37,860 --> 00:20:39,595 CONSISTENT INCREASES, SHOWN HERE 612 00:20:39,595 --> 00:20:41,797 FROM 2007 TO 2019, AND FOR 613 00:20:41,797 --> 00:20:43,232 GESTATIONAL DIABETES SHOWN HERE 614 00:20:43,232 --> 00:20:45,067 FROM 2011 TO 2019. 615 00:20:45,067 --> 00:20:46,969 IF WE LOOK BASED ON 616 00:20:46,969 --> 00:20:47,903 SELF-IDENTIFIED RACE AND 617 00:20:47,903 --> 00:20:49,672 ETHNICITY, WE SEE THE HIGHEST 618 00:20:49,672 --> 00:20:51,640 RATES FOR HYPERTENSIVE DISORDERS 619 00:20:51,640 --> 00:20:53,075 AMONG NON-HISPANIC BLACK 620 00:20:53,075 --> 00:20:54,610 INDIVIDUALS AND THE HIGHEST RATE 621 00:20:54,610 --> 00:20:58,214 FOR GESTATIONAL DIABETES AMONG 622 00:20:58,214 --> 00:21:05,387 NON-HISPANIC ASIAN INDIVIDUALS. 623 00:21:05,387 --> 00:21:06,288 ONE OF THE KEY QUESTIONS THAT 624 00:21:06,288 --> 00:21:07,923 OFTEN COMES UP WHEN WE LOOK AT 625 00:21:07,923 --> 00:21:08,791 THESE INCREASING TRENDS IS, IS 626 00:21:08,791 --> 00:21:09,992 PART OF THE REASON THAT WE'RE 627 00:21:09,992 --> 00:21:11,527 SEEING THESE PATTERNS AND 628 00:21:11,527 --> 00:21:13,696 INCREASES BECAUSE OF INCREASING 629 00:21:13,696 --> 00:21:19,301 MATERNAL AGE IN OUR POPULATION? 630 00:21:19,301 --> 00:21:21,403 SO IF WE TAKE A LOOK AT THE 631 00:21:21,403 --> 00:21:22,838 MATERNAL AGE DISTRIBUTION OVER 632 00:21:22,838 --> 00:21:25,241 TIME, PARTICULARLY BETWEEN 2007 633 00:21:25,241 --> 00:21:27,209 AND 2019, YOU CAN SEE HERE IN 634 00:21:27,209 --> 00:21:29,044 THIS COLOR-CODED DIAGRAM THAT 635 00:21:29,044 --> 00:21:30,913 WHILE THE MEAN AGE HAS INCREASED 636 00:21:30,913 --> 00:21:32,448 BY TWO YEARS, THE MAJORITY OF 637 00:21:32,448 --> 00:21:33,882 THAT INCREASE HAS ACTUALLY COME 638 00:21:33,882 --> 00:21:35,751 FROM A POSITIVE OR FAVORABLE 639 00:21:35,751 --> 00:21:37,152 DECLINE IN TEEN BIRTHS. 640 00:21:37,152 --> 00:21:39,855 SO THERE'S BEEN SOME SHIFT WITH 641 00:21:39,855 --> 00:21:41,056 GREATER BIRTHS OCCURRING IN THE 642 00:21:41,056 --> 00:21:46,729 30 TO 34 OR THAT KNEE ON GREEN N 643 00:21:46,729 --> 00:21:48,631 GREEN SHADED REGION, BUT A LOT 644 00:21:48,631 --> 00:21:51,800 OF THIS CHAIJ HAS COME FROM A 645 00:21:51,800 --> 00:21:52,434 FAVORABLE AGE DISTRIBUTION 646 00:21:52,434 --> 00:21:54,503 CHANGE. 647 00:21:54,503 --> 00:21:56,405 WHILE AGE IS INDEED A RELATIVE 648 00:21:56,405 --> 00:21:58,240 RISK FACTOR, WHEREBY OLDER AGE 649 00:21:58,240 --> 00:21:59,875 IS ASSOCIATED WITH HIGHER RISK 650 00:21:59,875 --> 00:22:02,177 OF HYPERTENSIVE DISORDERS OF 651 00:22:02,177 --> 00:22:03,379 PREGNANCY, IF WE LOOK AT THIS 652 00:22:03,379 --> 00:22:05,214 FROM AN ABSOLUTE FRAMEWORK, WE 653 00:22:05,214 --> 00:22:07,750 CAN SEE FROM THIS PIE CHART THAT 654 00:22:07,750 --> 00:22:12,121 NEARLY 50% OF CASES OF NEW ONSET 655 00:22:12,121 --> 00:22:13,322 HYPERTENSIVE DISORDERS ACTUALLY 656 00:22:13,322 --> 00:22:15,624 OCCURRED IN INDIVIDUALS AGED 20 657 00:22:15,624 --> 00:22:16,925 TO 29, SO THE PURPLE AND THE 658 00:22:16,925 --> 00:22:18,227 GREEN COLOR HERE. 659 00:22:18,227 --> 00:22:19,561 AND THAT REPRESENTS THAT A 660 00:22:19,561 --> 00:22:20,896 GREATER PROPORTION OF 661 00:22:20,896 --> 00:22:22,164 PREGNANCIES ARE OCCURRING IN 662 00:22:22,164 --> 00:22:23,932 THIS AGE RANGE, BUT IT 663 00:22:23,932 --> 00:22:26,468 HIGHLIGHTS THE IMPORTANCE OF WHO 664 00:22:26,468 --> 00:22:30,639 MAY NORMALLY BE QUALIFIED AS NOT 665 00:22:30,639 --> 00:22:33,242 GREATER THAN -- OR ADVANCED 666 00:22:33,242 --> 00:22:34,543 MATERNAL AGE REALLY EXPERIENCING 667 00:22:34,543 --> 00:22:35,678 A LARGE PROPORTION OF THE 668 00:22:35,678 --> 00:22:38,647 ABSOLUTE BURDEN. 669 00:22:38,647 --> 00:22:42,685 ANOTHER WAY TO LOOK AT THIS IS 670 00:22:42,685 --> 00:22:44,320 RELATED TO BIRTH COHORT EFFECTS. 671 00:22:44,320 --> 00:22:46,088 SO IF WE THINK ABOUT THE FACT 672 00:22:46,088 --> 00:22:49,358 THAT OVER TIME, INDIVIDUALS 673 00:22:49,358 --> 00:22:50,893 WHILE THE ACTUAL AGE AT WHICH 674 00:22:50,893 --> 00:22:52,561 THEY'RE GIVING BIRTH IS THE SAME 675 00:22:52,561 --> 00:22:54,396 BUT THEY THEMSELVES WERE BORN IN 676 00:22:54,396 --> 00:22:56,498 A LATER PERIOD, SO IF SOMEBODY 677 00:22:56,498 --> 00:22:59,668 WAS BORN BETWEEN 1996 TO 2004 678 00:22:59,668 --> 00:23:01,737 SHOWN HERE IN THE DARK BLUE, 679 00:23:01,737 --> 00:23:04,807 VERSUS SOMEBODY WHO WAS BORN IN 680 00:23:04,807 --> 00:23:06,909 AN EARLIER BIRTH COHORT, YOU CAN 681 00:23:06,909 --> 00:23:08,444 SEE BY THESE OVERLAPPING STACKED 682 00:23:08,444 --> 00:23:10,946 LINES THAT INDIVIDUALS BORN IN 683 00:23:10,946 --> 00:23:14,817 MORE RECENT GENERATIONS, 1996 TO 684 00:23:14,817 --> 00:23:17,319 2004 IN THE ORANGE, 1991 TO 685 00:23:17,319 --> 00:23:19,388 1999, ARE MUCH MORE LIKELY TO 686 00:23:19,388 --> 00:23:20,723 EXPERIENCE A HYPERTENSIVE 687 00:23:20,723 --> 00:23:23,692 DISORDER OF PREGNANCY EVEN AT 688 00:23:23,692 --> 00:23:26,095 THE SAME AGE AT DELIVERY. 689 00:23:26,095 --> 00:23:27,663 AND THIS REALLY HIGHLIGHTS THAT 690 00:23:27,663 --> 00:23:29,298 THERE'S AN ADDITIONAL BIRTH 691 00:23:29,298 --> 00:23:30,999 COHORT EFFECT THAT MAY BE 692 00:23:30,999 --> 00:23:33,535 RELATED TO SECULAR TRENDS OR 693 00:23:33,535 --> 00:23:35,337 POPULATION SHIFTS THAT HELP US 694 00:23:35,337 --> 00:23:37,306 BETTER UNDERSTAND THAT THIS IS 695 00:23:37,306 --> 00:23:39,241 NOT ALL SPECIFICALLY RELATED TO 696 00:23:39,241 --> 00:23:41,543 AGE OR PERIOD EFFECT, BUT BETTER 697 00:23:41,543 --> 00:23:43,078 UNDERSTANDING WHAT MAY BE 698 00:23:43,078 --> 00:23:44,813 CHANGING IN BIRTH COHORTS FOR 699 00:23:44,813 --> 00:23:46,348 PREGNANT INDIVIDUALS THEMSELVES. 700 00:23:46,348 --> 00:23:49,852 SO WHAT MIGHT THAT BE? 701 00:23:49,852 --> 00:23:51,520 SO LET'S TALK A LITTLE BIT ABOUT 702 00:23:51,520 --> 00:23:53,822 THE RATIONALE FOR CARDIOVASCULAR 703 00:23:53,822 --> 00:23:56,425 HEALTH PROMOTION AS PERHAPS THAT 704 00:23:56,425 --> 00:23:57,426 ANTECEDENT DRIVER TO WHAT'S 705 00:23:57,426 --> 00:23:59,661 CHANGING IN THE POPULATION AND 706 00:23:59,661 --> 00:24:02,898 OPPORTUNITIES TO INTERVENE. 707 00:24:02,898 --> 00:24:05,334 SO IF WE GO BACK TO OUR 708 00:24:05,334 --> 00:24:06,969 CONCEPTUAL DIAGRAM, WE'VE GONE 709 00:24:06,969 --> 00:24:08,771 THROUGH THE ADVERSE PREGNANCY 710 00:24:08,771 --> 00:24:09,538 OUT COME COMPLICATIONS. 711 00:24:09,538 --> 00:24:12,541 WE'VE LOOKED AT POSTPARTUM 712 00:24:12,541 --> 00:24:13,542 CARDIOVASCULAR DISEASE RISK SO 713 00:24:13,542 --> 00:24:15,444 LET'S SHIFT UPSTREAM. 714 00:24:15,444 --> 00:24:17,813 AND TALK ABOUT PREPREGNANCY 715 00:24:17,813 --> 00:24:19,681 CARDIOVASCULAR HEALTH, WHICH ARE 716 00:24:19,681 --> 00:24:22,151 RISK FACTORS FOR SHORT-TERM 717 00:24:22,151 --> 00:24:24,353 MATERNAL MORBIDITY AND MORTALITY 718 00:24:24,353 --> 00:24:26,121 AND LONG TERM MORBIDITY AND 719 00:24:26,121 --> 00:24:28,957 MORTALITY. 720 00:24:28,957 --> 00:24:31,160 SO WHAT DATA DO WE HAVE FOR 721 00:24:31,160 --> 00:24:32,294 PREPREGNANCY CARDIOVASCULAR 722 00:24:32,294 --> 00:24:33,695 HEALTH AND ADVERSE PREGNANCY 723 00:24:33,695 --> 00:24:34,029 OUTCOMES? 724 00:24:34,029 --> 00:24:36,098 THESE ARE DATA FROM THE NATIONAL 725 00:24:36,098 --> 00:24:38,967 CENTER FOR HEALTH STATISTICS, 726 00:24:38,967 --> 00:24:40,702 WHEREBY BIRTH CERTIFICATES WERE 727 00:24:40,702 --> 00:24:43,605 REVIEWED TO LOOK AT MATERNAL 728 00:24:43,605 --> 00:24:44,773 CHARACTERISTICS, SPECIFICALLY A 729 00:24:44,773 --> 00:24:46,341 CVH SCORE WAS CHARACTERIZED 730 00:24:46,341 --> 00:24:48,710 BASED ON OBESITY, DIABETES 731 00:24:48,710 --> 00:24:50,012 STATUS, HYPERTENSION STATUS AND 732 00:24:50,012 --> 00:24:51,113 SMOKING STATUS. 733 00:24:51,113 --> 00:24:55,918 SO A SCORE OF ZERO MEANT POOR 734 00:24:55,918 --> 00:24:57,252 CARDIOVASCULAR HEALTH WITH A 735 00:24:57,252 --> 00:24:58,487 GRADED DOSE DEPENDENT RESPONSE 736 00:24:58,487 --> 00:25:00,556 ASSOCIATED WITH GREATER RISK OF 737 00:25:00,556 --> 00:25:01,423 ADVERSE PREGNANCY OUTCOMES WITH 738 00:25:01,423 --> 00:25:02,958 A HIGHER BURDEN OF THESE RISK 739 00:25:02,958 --> 00:25:04,927 FACTORS, AND THAT WAS SEEN FROM 740 00:25:04,927 --> 00:25:06,662 MATERNAL ICU ADMISSION, PRETERM 741 00:25:06,662 --> 00:25:11,033 BIRTH AND LOW BIRTH WEIGHT. 742 00:25:11,033 --> 00:25:13,569 IN ADDITION TO THESE MORE CRUDE 743 00:25:13,569 --> 00:25:15,304 RISK FACTORS, THIS ANALYSIS FROM 744 00:25:15,304 --> 00:25:18,040 THE NEW MOM TO BE STUDY LOOKED 745 00:25:18,040 --> 00:25:20,142 SPECIFICALLY AT BLOOD PRESSURE 746 00:25:20,142 --> 00:25:21,543 LEVELS, EVEN IN THE ABSENCE OF 747 00:25:21,543 --> 00:25:23,846 CHRONIC HYPERTENSION REQUIRING 748 00:25:23,846 --> 00:25:25,380 MEDICATION, AND WHAT THE 749 00:25:25,380 --> 00:25:27,883 ASSOCIATION WITH COMPLICATIONS 750 00:25:27,883 --> 00:25:29,852 OF PREECLAMPSIA AND BIRTH 751 00:25:29,852 --> 00:25:30,752 COMPLICATIONS DURING PREGNANCY 752 00:25:30,752 --> 00:25:31,286 WAS. 753 00:25:31,286 --> 00:25:33,589 YOU CAN SEE IN THE CATEGORIES 754 00:25:33,589 --> 00:25:36,892 HERE ABOUT 10% OF INDIVIDUALS 755 00:25:36,892 --> 00:25:38,427 QUALIFIED IN THE STAGE ONE 756 00:25:38,427 --> 00:25:39,962 HYPERTENSION CATEGORY, ABOUT 10% 757 00:25:39,962 --> 00:25:41,597 HAD ELEVATED BLOOD PRESSURE, AND 758 00:25:41,597 --> 00:25:43,232 THE MAJORITY HAD NORMAL BLOOD 759 00:25:43,232 --> 00:25:43,899 PRESSURE. 760 00:25:43,899 --> 00:25:46,301 AND SO YOU CAN ALREADY SEE THE 761 00:25:46,301 --> 00:25:48,370 SEPARATION BASED ON HAVING AN 762 00:25:48,370 --> 00:25:50,038 ELEVATED OR STAGE ONE 763 00:25:50,038 --> 00:25:51,907 HYPERTENSION BLOOD PRESSURE IN 764 00:25:51,907 --> 00:25:53,375 EARLY PREGNANCY AT A MEAN 765 00:25:53,375 --> 00:25:54,643 GESTATIONAL AGE OF 12 WEEKS WITH 766 00:25:54,643 --> 00:25:58,480 A HIGHER RISK OF PRE-ECLAMPSIA 767 00:25:58,480 --> 00:25:59,581 NOW WHEN GESTATIONAL 768 00:25:59,581 --> 00:26:03,385 HYPERTENSION WAS ADDED THERE WAS 769 00:26:03,385 --> 00:26:05,521 EVEN A HIGHER ONE IN THREE RISK 770 00:26:05,521 --> 00:26:07,589 OF DEVELOPING EITHER GESTATIONAL 771 00:26:07,589 --> 00:26:09,024 HYPERTENSION OR PREECLAMPSIA AND 772 00:26:09,024 --> 00:26:10,659 THOSE IN THE STAGE ONE GROUP HAD 773 00:26:10,659 --> 00:26:14,396 A 40% INCIDENCE OF DEVELOPING 774 00:26:14,396 --> 00:26:17,165 EITHER GESTATIONAL HYPERTENSION 775 00:26:17,165 --> 00:26:18,133 OR PRE-ECLAMPSIA THE OTHER 776 00:26:18,133 --> 00:26:18,901 INTERESTING THING WAS AMONG 777 00:26:18,901 --> 00:26:20,168 THOSE WHO HAD AN INCREASE IN 778 00:26:20,168 --> 00:26:21,503 BLOOD PRESSURE FROM THIS FIRST 779 00:26:21,503 --> 00:26:22,871 TRIMESTER TO SECOND TRIMESTER 780 00:26:22,871 --> 00:26:24,840 VISIT WERE MUCH MORE LIKELY TO 781 00:26:24,840 --> 00:26:26,742 DEVELOP PREECLAMPSIA AS WELL, 782 00:26:26,742 --> 00:26:28,577 HIGHLIGHTING THE DYNAMIC NATURE 783 00:26:28,577 --> 00:26:29,678 OF BLOOD PRESSURE CHANGE DURING 784 00:26:29,678 --> 00:26:30,979 PREGNANCY AS AN IMPORTANT 785 00:26:30,979 --> 00:26:35,951 PREDICTOR. 786 00:26:35,951 --> 00:26:38,120 WHILE THESE DATA HELP US 787 00:26:38,120 --> 00:26:40,322 IDENTIFY THAT PREPREGNANCY 788 00:26:40,322 --> 00:26:44,159 CARDIOVASCULAR HELP AS WELL 789 00:26:44,159 --> 00:26:45,694 AS -- ARE REALLY IMPORTANT FOR 790 00:26:45,694 --> 00:26:47,029 PREGNANCY COMPLICATION AND LONG 791 00:26:47,029 --> 00:26:48,397 TERM CARDIOVASCULAR RISK, IF WE 792 00:26:48,397 --> 00:26:50,832 TAKE A LOOK AT THE OVERALL 793 00:26:50,832 --> 00:26:52,234 POPULATION CHANGE, WE SEE 794 00:26:52,234 --> 00:26:53,468 CARDIOVASCULAR HEALTH IS 795 00:26:53,468 --> 00:26:54,536 DECLINING OVERALL IN ALL 796 00:26:54,536 --> 00:26:55,070 INDIVIDUALS. 797 00:26:55,070 --> 00:26:58,273 RATES OF OBESITY AND SEVERE 798 00:26:58,273 --> 00:27:00,075 OBESITY ARE INCREASING, RATES OF 799 00:27:00,075 --> 00:27:02,044 PREDIABETES AND DIABETES, AND 800 00:27:02,044 --> 00:27:02,978 PARTICULARLY AMONG ADOLESCENTS 801 00:27:02,978 --> 00:27:04,980 AND YOUNG ADULTS, WHO ARE IN 802 00:27:04,980 --> 00:27:09,017 THEIR REPRODUCTIVE YEARS. 803 00:27:09,017 --> 00:27:10,018 DATA FROM THE NATIONAL CENTER 804 00:27:10,018 --> 00:27:11,787 FOR HEALTH STATISTICS HELPS US 805 00:27:11,787 --> 00:27:13,188 ALSO LOOK AT SOME OF THESE 806 00:27:13,188 --> 00:27:15,924 TRENDS WHEREBY IN EACH AGE 807 00:27:15,924 --> 00:27:17,626 GROUP, SHOWN HERE FOR 15 TO 24, 808 00:27:17,626 --> 00:27:20,996 25 TO 34 AND 35 TO 44, WE SEE A 809 00:27:20,996 --> 00:27:22,431 DECLINE IN OPTIMAL 810 00:27:22,431 --> 00:27:23,832 CARDIOVASCULAR HEALTH, WHEREBY 811 00:27:23,832 --> 00:27:26,802 OPTIMAL IS DEFINED AS NORMAL 812 00:27:26,802 --> 00:27:28,136 BMI, ABSENCE OF DIABETES OR 813 00:27:28,136 --> 00:27:29,037 HYPERTENSION. 814 00:27:29,037 --> 00:27:30,205 IN THE SECOND FIGURE, WE SEE 815 00:27:30,205 --> 00:27:32,608 THAT THERE ARE ALSO SIGNIFICANT 816 00:27:32,608 --> 00:27:34,476 DISPARITIES BY ADVERSE SOCIAL 817 00:27:34,476 --> 00:27:36,445 FACTORS AS DESIGNATED BY 818 00:27:36,445 --> 00:27:40,082 QUALIFYING OR RECEIVING WIC 819 00:27:40,082 --> 00:27:40,782 SUPPORT DURING PREGNANCY. 820 00:27:40,782 --> 00:27:42,985 YOU SEE THAT SIGNIFICANT 821 00:27:42,985 --> 00:27:44,920 DIFFERENCE IN OPTIMAL CVH IN 822 00:27:44,920 --> 00:27:46,888 THOSE RECEIVING WIC SUPPORT AS 823 00:27:46,888 --> 00:27:48,256 WELL AS CONSISTENT DECLINES FOR 824 00:27:48,256 --> 00:27:51,660 BOTH. 825 00:27:51,660 --> 00:27:53,595 SO I POSIT AND HOPEFULLY WHAT 826 00:27:53,595 --> 00:27:55,130 WE'VE LOOKED AT SO FAR 827 00:27:55,130 --> 00:27:56,198 HIGHLIGHTS THAT MATERNAL 828 00:27:56,198 --> 00:27:57,265 MORBIDITY IS REALLY THE TIP OF 829 00:27:57,265 --> 00:27:59,334 THE ICEBERG WHEN WE'RE THINKING 830 00:27:59,334 --> 00:28:02,337 ABOUT BOTH PREGNANCY-SPECIFIC 831 00:28:02,337 --> 00:28:03,739 COMPLICATIONS AND LONG TERM 832 00:28:03,739 --> 00:28:05,374 CARDIOVASCULAR HEALTH. 833 00:28:05,374 --> 00:28:07,476 AND REALLY WHAT WE WANT TO DO IS 834 00:28:07,476 --> 00:28:08,810 MOVE BELOW THE SURFACE TO THINK 835 00:28:08,810 --> 00:28:10,779 ABOUT THE GREATER POPULATION 836 00:28:10,779 --> 00:28:12,180 LEVEL IMPACT THAT WE CAN HAVE 837 00:28:12,180 --> 00:28:14,116 WITH A FOCUS ON CARDIOVASCULAR 838 00:28:14,116 --> 00:28:15,817 HEALTH THROUGHOUT THE PERIPARTUM 839 00:28:15,817 --> 00:28:21,723 PERIOD. 840 00:28:21,723 --> 00:28:24,259 AHA, ACC AND ACOG HAVE ALL 841 00:28:24,259 --> 00:28:26,128 HIGHLIGHTED THE REPRODUCTIVE 842 00:28:26,128 --> 00:28:27,996 YEARS AS AN IMPORTANT PERIOD TO 843 00:28:27,996 --> 00:28:34,102 FOCUS ON CARDIOVASCULAR HEALTH 844 00:28:34,102 --> 00:28:37,172 PROMOTION, AND AN AHA/ACOG 845 00:28:37,172 --> 00:28:38,040 COMBINED PRESIDENTIAL ADVISORY 846 00:28:38,040 --> 00:28:39,708 THAT PROMOTED RISK 847 00:28:39,708 --> 00:28:41,009 IDENTIFICATION AND REDUCTION OF 848 00:28:41,009 --> 00:28:41,910 CARDIOVASCULAR DISEASE DURING 849 00:28:41,910 --> 00:28:44,980 THE REPRODUCTIVE YEARS. 850 00:28:44,980 --> 00:28:47,149 ONE OF THE KEY PHRASES THAT HAS 851 00:28:47,149 --> 00:28:48,483 BECOME MORE AND MORE COMMON IS 852 00:28:48,483 --> 00:28:50,786 THIS IDEA OF A FOURTH TRIMESTER, 853 00:28:50,786 --> 00:28:52,754 THE 12 WEEKS THAT FOLLOW 854 00:28:52,754 --> 00:28:54,189 DELIVERY, AS A KEY TIME FOR 855 00:28:54,189 --> 00:28:55,824 THOSE WHO HAVE DELIVERY 856 00:28:55,824 --> 00:28:57,559 COMPLICATED BY ADVERSE PREGNANCY 857 00:28:57,559 --> 00:29:00,228 OUTCOMES TO BE CONNECTED TO AND 858 00:29:00,228 --> 00:29:02,164 TRANSITION TO PRIMARY CARE. 859 00:29:02,164 --> 00:29:03,932 THIS NICE SCHEMATIC FROM A 860 00:29:03,932 --> 00:29:05,801 RECENT REVIEW IN JAMA CARDIOLOGY 861 00:29:05,801 --> 00:29:07,436 HIGHLIGHTED THIS GROWING CONCEPT 862 00:29:07,436 --> 00:29:10,305 OF TRANSITIONAL CLINICS THAT CAN 863 00:29:10,305 --> 00:29:11,840 PERFORM EDUCATION, COUNSELING, 864 00:29:11,840 --> 00:29:14,476 SCREENING AND RISK ASSESSMENT, 865 00:29:14,476 --> 00:29:17,012 MEDICATION MANAGEMENT AND THAT 866 00:29:17,012 --> 00:29:17,879 IMPORTANT TRANSITION TO PRIMARY 867 00:29:17,879 --> 00:29:18,880 CARE FOR INDIVIDUALS WHO ARE 868 00:29:18,880 --> 00:29:20,082 IDENTIFIED AS HAVING HIGHER RISK 869 00:29:20,082 --> 00:29:22,250 DUE TO THEIR COMPLICATION OF 870 00:29:22,250 --> 00:29:25,120 ADVERSE PREGNANCY OUT COME. 871 00:29:25,120 --> 00:29:26,188 OUTCOME. 872 00:29:26,188 --> 00:29:28,523 ONE OF THE CHALLENGES WITH THIS 873 00:29:28,523 --> 00:29:30,258 CONSTRUCTION HAS BEEN THE 874 00:29:30,258 --> 00:29:32,494 INABILITY FOR INDIVIDUALS TO 875 00:29:32,494 --> 00:29:33,895 COME IN IN PERSON, ESPECIALLY 876 00:29:33,895 --> 00:29:37,332 WITH THE COVID PANDEMIC, THE 877 00:29:37,332 --> 00:29:39,735 INCREASING USE OF TELEHEALTH 878 00:29:39,735 --> 00:29:41,603 MADE DIAGRAMS OR CONSTRUCTS LIKE 879 00:29:41,603 --> 00:29:42,904 THIS MORE AVAILABLE. 880 00:29:42,904 --> 00:29:44,973 THIS WAS A REPORT THAT WAS 881 00:29:44,973 --> 00:29:47,008 PUBLISHED FROM A ACADEMIC CENTER 882 00:29:47,008 --> 00:29:49,745 THAT INCORPORATED A 883 00:29:49,745 --> 00:29:50,345 MULTIDISCIPLINARY TELEHEALTH 884 00:29:50,345 --> 00:29:52,214 CLINIC TO ALLOW INDIVIDUALS TO 885 00:29:52,214 --> 00:29:55,117 BE ABLE TO GO HOME SOONER WITH 886 00:29:55,117 --> 00:29:57,085 HOME BLOOD PRESSURE MONITORING 887 00:29:57,085 --> 00:29:59,921 PROGRAMS, AS WELL AS STAY IN AN 888 00:29:59,921 --> 00:30:00,922 EXTENDED HOME BLOOD PRESSURE 889 00:30:00,922 --> 00:30:02,157 MONITORING PROGRAM POSTPARTUM TO 890 00:30:02,157 --> 00:30:03,959 CONTINUE TO MONITOR CLOSELY FOR 891 00:30:03,959 --> 00:30:04,659 BLOOD PRESSURE COMPARED WITH THE 892 00:30:04,659 --> 00:30:06,094 STAN 893 00:30:06,094 --> 00:30:07,662 STANDARD OF CARE WHICH AFTER 894 00:30:07,662 --> 00:30:09,097 THAT FIRST 14 DAY BLOOD PRESSURE 895 00:30:09,097 --> 00:30:11,366 CHECK MAY HAVE LEFT WITH 896 00:30:11,366 --> 00:30:12,134 SOMETHING -- WITH THE CLINIC 897 00:30:12,134 --> 00:30:14,035 VISIT SOMEWHERE IN THE 2 TO 898 00:30:14,035 --> 00:30:15,237 6 MONTH PERIOD AND REALLY A LOT 899 00:30:15,237 --> 00:30:17,105 OF PEOPLE GETTING LOST AND NOT 900 00:30:17,105 --> 00:30:21,710 HAVING FOLLOW-UP. 901 00:30:21,710 --> 00:30:24,246 IT'S REALLY IMPORTANT TO THINK 902 00:30:24,246 --> 00:30:25,247 ABOUT AMONG INDIVIDUALS WHO 903 00:30:25,247 --> 00:30:26,314 EXPERIENCE A HYPERTENSIVE 904 00:30:26,314 --> 00:30:28,049 DISORDER OF PREGNANCY, MANY NO 905 00:30:28,049 --> 00:30:30,152 LONGER NEED MEDICATIONS, AND MAY 906 00:30:30,152 --> 00:30:32,554 NOT BE CLOSELY FOLLOWED FOR 907 00:30:32,554 --> 00:30:34,656 OPTIMAL LIFESTYLE INTERVENTIONS. 908 00:30:34,656 --> 00:30:36,358 SO THIS REALLY NICE WORK THAT 909 00:30:36,358 --> 00:30:40,362 WAS FUNDED BY NHLBI ASKED THE 910 00:30:40,362 --> 00:30:42,230 QUESTION OF TEXT-BASED 911 00:30:42,230 --> 00:30:43,365 GAMIFICATION, SO COULD WE 912 00:30:43,365 --> 00:30:45,667 PROMOTE PHYSICAL ACTIVITY IN A 913 00:30:45,667 --> 00:30:47,402 GAMIFIED APPROACH TO HELP 914 00:30:47,402 --> 00:30:48,503 IMPROVE STEP COUNTS? 915 00:30:48,503 --> 00:30:51,573 SO THE STUDY LOOKED AT 127 916 00:30:51,573 --> 00:30:53,542 PARTICIPANTS WITH A MEAN AGE OF 917 00:30:53,542 --> 00:30:55,610 32 WHO HAD EXPERIENCED A 918 00:30:55,610 --> 00:30:56,411 HYPERTENSIVE DISORDER OF 919 00:30:56,411 --> 00:30:58,947 PREGNANCY AND RANDOMIZED THEM TO 920 00:30:58,947 --> 00:31:00,916 A TEXT-BASED GAMIFICATION 921 00:31:00,916 --> 00:31:03,218 APPROACH WHERE BOTH CONTROL AND 922 00:31:03,218 --> 00:31:05,220 INTERVENTION RECEIVED A FITBIT 923 00:31:05,220 --> 00:31:06,421 TO TRACK THEIR STEP COUNTS, AND 924 00:31:06,421 --> 00:31:08,089 YOU SEE HERE THAT THE 925 00:31:08,089 --> 00:31:08,957 INTERVENTION SHOWN IN THE DARK 926 00:31:08,957 --> 00:31:10,525 RED HAD A MUCH HIGHER STEP COUNT 927 00:31:10,525 --> 00:31:12,060 THAN THE CONTROL. 928 00:31:12,060 --> 00:31:13,562 NOW, I ALSO DO WANT TO POINT OUT 929 00:31:13,562 --> 00:31:17,566 THAT THE DELTA HERE WAS ABOUT 930 00:31:17,566 --> 00:31:18,867 600 STEPS, WHICH IS ABOUT A 931 00:31:18,867 --> 00:31:20,969 THIRD OF A MILE OR ON AN AVERAGE 932 00:31:20,969 --> 00:31:22,070 WALKING PACE ABOUT FIVE MINUTES 933 00:31:22,070 --> 00:31:23,772 OF WALKING EXTRA PER DAY. 934 00:31:23,772 --> 00:31:25,340 NOW, WHILE THAT MAY NOT SEEM 935 00:31:25,340 --> 00:31:27,943 LIKE A LOT, THE COMBINATION OF 936 00:31:27,943 --> 00:31:30,412 DOING THAT ON A FREQUENT AND 937 00:31:30,412 --> 00:31:33,081 CONTINUOUS BASIS MAY HAVE 938 00:31:33,081 --> 00:31:34,482 LONG-STANDING EFFECT, BUT I 939 00:31:34,482 --> 00:31:35,350 THINK ONE OF THE CHALLENGE THAT 940 00:31:35,350 --> 00:31:38,286 WE CONTINUE TO HAVE IS HOW DO WE 941 00:31:38,286 --> 00:31:40,255 SUSTAIN INCREASES AND MAINTAIN 942 00:31:40,255 --> 00:31:43,358 PHYSICAL ACTIVITY IN BIRTHING 943 00:31:43,358 --> 00:31:47,762 ADULTS AS WELL AS ALL ADULTS. 944 00:31:47,762 --> 00:31:49,798 ONE OF THE OTHER STRATEGIES THAT 945 00:31:49,798 --> 00:31:51,900 HAS BEEN PROMOTED HAS BEEN THE 946 00:31:51,900 --> 00:31:54,469 SUPPORT OF LACTATION TO PROMOTE 947 00:31:54,469 --> 00:31:56,438 METABOLIC HEALTH POSTPARTUM. 948 00:31:56,438 --> 00:31:57,706 THE FIRST GRAPH HERE SHOWS SOME 949 00:31:57,706 --> 00:32:02,244 REALLY NICE DATA FROM THE CARDIA 950 00:32:02,244 --> 00:32:05,080 COHORT, LOOKING AT DURATION OF 951 00:32:05,080 --> 00:32:06,948 LACTATION FROM NONE TO GREATER 952 00:32:06,948 --> 00:32:08,950 THAN ZERO TO SIX MONTHS, 6 TO 953 00:32:08,950 --> 00:32:11,786 12, GREATER THAN OR EQUAL TO 12, 954 00:32:11,786 --> 00:32:13,655 AND COMBINED WITH ANY 955 00:32:13,655 --> 00:32:14,456 LACTATION -- OR COMBINED WITH 956 00:32:14,456 --> 00:32:17,325 THE OVERALL POPULATION TO LOOK 957 00:32:17,325 --> 00:32:19,527 AT THE INCIDENCE OF DIABETES IN 958 00:32:19,527 --> 00:32:21,463 FOLLOW-UP, AND YOU CAN SEE THOSE 959 00:32:21,463 --> 00:32:24,332 INDIVIDUALS THAT HAD GREATER 960 00:32:24,332 --> 00:32:25,767 DURATION OF LACTATION HAVE LOWER 961 00:32:25,767 --> 00:32:27,535 INCIDENCE OF DIABETES, AND WHEN 962 00:32:27,535 --> 00:32:29,471 YOU STRATIFY BY GESTATIONAL 963 00:32:29,471 --> 00:32:30,972 DIABETES OR NON-GESTATIONAL 964 00:32:30,972 --> 00:32:32,574 DIABETES, YOU SEE A SIMILAR 965 00:32:32,574 --> 00:32:32,908 PATTERN. 966 00:32:32,908 --> 00:32:34,242 SO THERE IS AN EFFECT 967 00:32:34,242 --> 00:32:35,477 MODIFICATION BY GESTATIONAL 968 00:32:35,477 --> 00:32:36,044 DIABETES STATUS. 969 00:32:36,044 --> 00:32:38,213 SO THAT IS OBSERVATIONAL DATA 970 00:32:38,213 --> 00:32:41,950 THAT SUPPORTS AN ASSOCIATION. 971 00:32:41,950 --> 00:32:43,518 UNFORTUNATELY, GIVEN THE 972 00:32:43,518 --> 00:32:44,519 STRUCTURAL AND PERSONAL BARRIERS 973 00:32:44,519 --> 00:32:47,589 THAT MAY EXIST TO LACTATION, WE 974 00:32:47,589 --> 00:32:49,491 DO SEE VERY LOW RATES IN THE 975 00:32:49,491 --> 00:32:51,960 UNITED STATES WITH AT 6 MONTHS, 976 00:32:51,960 --> 00:32:55,130 ANY BREASTFEEDING AT ABOUT 56% 977 00:32:55,130 --> 00:32:57,165 AND EXCLUSIVE BREASTFEEDING AT 978 00:32:57,165 --> 00:32:59,834 25%. 979 00:32:59,834 --> 00:33:02,003 WE KNOW THERE ARE MANY BARRIERS 980 00:33:02,003 --> 00:33:05,106 THAT EXIST INCLUDING AT A POLICY 981 00:33:05,106 --> 00:33:07,208 LEVEL WITH NEED FOR PARENTAL 982 00:33:07,208 --> 00:33:10,512 LEAVE AT A COMMUNITY LEVEL, 983 00:33:10,512 --> 00:33:11,279 INSTITUTIONAL, INTERPERSONAL AND 984 00:33:11,279 --> 00:33:12,614 INDIVIDUAL LEVEL THAT CAN REALLY 985 00:33:12,614 --> 00:33:13,715 CREATE CHALLENGES FOR SUPPORTING 986 00:33:13,715 --> 00:33:15,784 LACTATION. 987 00:33:15,784 --> 00:33:16,885 UNDERSTANDING THESE CHALLENGES 988 00:33:16,885 --> 00:33:18,687 AND ADDRESSING THEM IN AN 989 00:33:18,687 --> 00:33:20,188 EQUITABLE FRAMEWORK SHOWN HERE 990 00:33:20,188 --> 00:33:23,758 AS A SOCIOECOLOGICAL MODEL THAT 991 00:33:23,758 --> 00:33:25,694 CAN REALLY THINK ABOUT THIS AT A 992 00:33:25,694 --> 00:33:27,095 POLICY LEVEL AND ORGANIZATIONAL 993 00:33:27,095 --> 00:33:28,096 LEVEL, COMMUNITY LEVEL, AS WELL 994 00:33:28,096 --> 00:33:28,997 AS INDIVIDUAL LEVEL S REALLY 995 00:33:28,997 --> 00:33:29,965 IMPORTANT. 996 00:33:29,965 --> 00:33:31,633 ONE OF THE THINGS THAT CAN OFTEN 997 00:33:31,633 --> 00:33:33,601 OCCUR WHEN WE TALK ABOUT 998 00:33:33,601 --> 00:33:35,136 LACTATION SUPPORT IS ALL OF THIS 999 00:33:35,136 --> 00:33:37,038 FOCUS THAT OCCURS ON THE 1000 00:33:37,038 --> 00:33:38,606 BIRTHING ADULT, WITHOUT 1001 00:33:38,606 --> 00:33:40,875 CONSIDERATION FOR THE EXTERNAL 1002 00:33:40,875 --> 00:33:42,510 DRIVERS THAT MAY BE OUT OF THEIR 1003 00:33:42,510 --> 00:33:44,746 CONTROL THAT CAN OFTEN 1004 00:33:44,746 --> 00:33:45,480 EXACERBATE AN ALREADY DIFFICULT 1005 00:33:45,480 --> 00:33:51,820 SITUATION. 1006 00:33:51,820 --> 00:33:53,588 SO WE'RE LOOKING AT A LOT OF 1007 00:33:53,588 --> 00:33:54,889 THIS DATA THAT HELP US IDENTIFY 1008 00:33:54,889 --> 00:33:56,691 THE POSTPARTUM PERIOD AS AN 1009 00:33:56,691 --> 00:33:58,893 IDEAL TIME TO MEASURE AND MODIFY 1010 00:33:58,893 --> 00:33:59,527 CARDIOVASCULAR HEALTH. 1011 00:33:59,527 --> 00:34:01,429 SO HOW CAN WE DO IT? 1012 00:34:01,429 --> 00:34:03,431 IN JAMA LAST YEAR, WE PROPOSED 1013 00:34:03,431 --> 00:34:05,934 LEVERAGING THE LIFE'S ESSENTIAL 1014 00:34:05,934 --> 00:34:07,168 8 FRAMEWORK, REALLY AS A 1015 00:34:07,168 --> 00:34:08,937 CONTINUOUS TIME THINKING ABOUT 1016 00:34:08,937 --> 00:34:09,904 THE PREPREGNANCY PERIOD, THE 1017 00:34:09,904 --> 00:34:12,007 PREGNANCY PERIOD, AND THE 1018 00:34:12,007 --> 00:34:14,142 POSTPARTUM PERIOD TO THINK ABOUT 1019 00:34:14,142 --> 00:34:16,544 MEASUREMENT AND MODIFICATION AS 1020 00:34:16,544 --> 00:34:18,847 NEEDED OF THESE EIGHT COMPONENTS 1021 00:34:18,847 --> 00:34:21,049 OF LIFE'S ESSENTIAL EIGHT, 1022 00:34:21,049 --> 00:34:22,484 SPECIFICALLY, DIETARY 1023 00:34:22,484 --> 00:34:25,220 ASSESSMENT, PHYSICAL ACTIVITY, 1024 00:34:25,220 --> 00:34:27,655 NICOTINE EXPOSURE AND AVOIDANCE, 1025 00:34:27,655 --> 00:34:29,691 SLEEP HEALTH, WHICH WAS THE 1026 00:34:29,691 --> 00:34:32,694 NEWEST VARIABLE THAT WAS 1027 00:34:32,694 --> 00:34:34,763 INCLUDED IN THE AHA 1028 00:34:34,763 --> 00:34:36,398 CARDIOVASCULAR HEALTH CONSTRUCT, 1029 00:34:36,398 --> 00:34:38,500 BODY MASS INDEX, BLOOD PRESSURE 1030 00:34:38,500 --> 00:34:39,634 MONITORING, BLOOD GLUCOSE AND 1031 00:34:39,634 --> 00:34:40,735 BLOOD LIPID SCREENING. 1032 00:34:40,735 --> 00:34:43,338 ONE OF THE THINGS THAT WE 1033 00:34:43,338 --> 00:34:44,072 HIGHLIGHTED WAS THE IMPORTANCE 1034 00:34:44,072 --> 00:34:45,440 OF DIET AND PHYSICAL ACTIVITY 1035 00:34:45,440 --> 00:34:46,875 SCREENING WITHIN THE CLINICAL 1036 00:34:46,875 --> 00:34:48,643 SYSTEM THAT IS OFTEN NOT COVERED 1037 00:34:48,643 --> 00:34:51,980 BOTH AT THE POSTPARTUM VISIT OR 1038 00:34:51,980 --> 00:34:54,182 IN TRANSITIONS TO PRIMARY CARE. 1039 00:34:54,182 --> 00:34:56,451 THE OTHER QUESTION THAT REMAINS 1040 00:34:56,451 --> 00:34:59,821 IS HOW FREQUENTLY SHOULD BLOOD 1041 00:34:59,821 --> 00:35:01,589 PRESSURE, BLOOD GLUCOSE AND 1042 00:35:01,589 --> 00:35:04,993 BLOOD LIPIDS BE MEASURED AFTER 1043 00:35:04,993 --> 00:35:07,295 AN INDIVIDUAL IS POSTPARTUM, HOW 1044 00:35:07,295 --> 00:35:09,264 SOON AFTER POSTPARTUM AND HOW 1045 00:35:09,264 --> 00:35:10,865 FREQUENTLY, AND SHOULD THAT 1046 00:35:10,865 --> 00:35:14,235 DIFFER FOR INDIVIDUALS WITH 1047 00:35:14,235 --> 00:35:15,437 ADVERSE POST PREGNANCY OUT COME, 1048 00:35:15,437 --> 00:35:16,971 GOING ON TO DEVELOP CHRONIC 1049 00:35:16,971 --> 00:35:20,475 HYPERTENSION AND DIABETES. 1050 00:35:20,475 --> 00:35:22,777 WHEN WE TALK ABOUT POSTPARTUM 1051 00:35:22,777 --> 00:35:23,545 INTERVENTIONS, IT'S IMPORTANT TO 1052 00:35:23,545 --> 00:35:25,180 REMEMBER THAT THESE COULD ALSO 1053 00:35:25,180 --> 00:35:27,215 SERVE AS INTERPREGNANCY 1054 00:35:27,215 --> 00:35:28,850 INTERVENTIONS, WHILE POSTPARTUM 1055 00:35:28,850 --> 00:35:31,019 MAY HELP TO MODIFY 1056 00:35:31,019 --> 00:35:32,020 CARDIOVASCULAR HEALTH ACROSS THE 1057 00:35:32,020 --> 00:35:34,155 LIFE COURSE FOR THE BIRTHING 1058 00:35:34,155 --> 00:35:35,457 INDIVIDUAL, OFTENTIMES PEOPLE 1059 00:35:35,457 --> 00:35:36,758 MAY BECOME PREGNANT AGAIN AND 1060 00:35:36,758 --> 00:35:41,796 THIS REPRESENTS AN END TERM 1061 00:35:41,796 --> 00:35:43,264 PREGNANCY INTERVENTION OR 1062 00:35:43,264 --> 00:35:44,099 PRETERM PREGNANCY INTERVENTION 1063 00:35:44,099 --> 00:35:45,233 FOR THE NEXT PREGNANCY. 1064 00:35:45,233 --> 00:35:46,434 NEXT SLIDE. 1065 00:35:46,434 --> 00:35:48,069 IT'S REALLY IMPORTANT WHEN WE 1066 00:35:48,069 --> 00:35:50,105 THINK ABOUT PREGNANCY 1067 00:35:50,105 --> 00:35:51,306 CARDIOVASCULAR HEALTH AND 1068 00:35:51,306 --> 00:35:52,640 POSTPARTUM CARDIOVASCULAR HEALTH 1069 00:35:52,640 --> 00:35:54,142 TO REMEMBER THAT THIS IS 1070 00:35:54,142 --> 00:35:56,277 SOMETHING THAT TRACKS VERY 1071 00:35:56,277 --> 00:35:57,912 CONSISTENTLY. 1072 00:35:57,912 --> 00:36:00,982 AND OFTENTIMES WHERE POSTPARTUM 1073 00:36:00,982 --> 00:36:02,851 CARDIOVASCULAR HEALTH IS, IS 1074 00:36:02,851 --> 00:36:04,786 REALLY DEFINED BY WHERE 1075 00:36:04,786 --> 00:36:05,620 PREGNANCY CARDIOVASCULAR HEALTH 1076 00:36:05,620 --> 00:36:07,822 IS, WHICH IS DEFINED BY 1077 00:36:07,822 --> 00:36:08,456 PREPREGNANCY CARDIOVASCULAR 1078 00:36:08,456 --> 00:36:11,459 HEALTH. 1079 00:36:11,459 --> 00:36:13,561 AND THIS WAS THE FOCUS OF A 1080 00:36:13,561 --> 00:36:15,430 RECENT AHA SCIENTIFIC STATEMENT 1081 00:36:15,430 --> 00:36:17,532 THAT I WAS FORTUNATE TO WORK ON 1082 00:36:17,532 --> 00:36:21,336 WITH DR. WEI FROM THE NHLBI AND 1083 00:36:21,336 --> 00:36:22,237 MANY OR COLLEAGUES THAT 1084 00:36:22,237 --> 00:36:23,571 HIGHLIGHTED THE IMPORTANCE OF 1085 00:36:23,571 --> 00:36:25,306 THE PREPREGNANCY PERIOD AS 1086 00:36:25,306 --> 00:36:26,875 PERHAPS THE ZERO TRIMESTER, A 1087 00:36:26,875 --> 00:36:27,842 PERIOD OF TIME WHERE WE MAY HAVE 1088 00:36:27,842 --> 00:36:29,644 THE GREATEST YIELD BY BEING ABLE 1089 00:36:29,644 --> 00:36:32,947 TO FOCUS ON OPTIMIZING 1090 00:36:32,947 --> 00:36:33,815 CARDIOVASCULAR HEALTH BEFORE AN 1091 00:36:33,815 --> 00:36:35,383 INDIVIDUAL BECOMES PREGNANT. 1092 00:36:35,383 --> 00:36:36,718 AND IF WE THINK ABOUT THIS 1093 00:36:36,718 --> 00:36:38,553 WITHIN THE LIFECYCLE OR FULL 1094 00:36:38,553 --> 00:36:40,188 LIFE COURSE, THE PREPREGNANCY 1095 00:36:40,188 --> 00:36:43,291 PERIOD REALLY INFORMS PREGNANCY 1096 00:36:43,291 --> 00:36:44,492 AND INTERPREGNANCY 1097 00:36:44,492 --> 00:36:45,493 CARDIOVASCULAR HEALTH AND FUTURE 1098 00:36:45,493 --> 00:36:46,928 RISK FOR CARDIOVASCULAR DISEASE 1099 00:36:46,928 --> 00:36:48,997 FOR THE BIRTHING INDIVIDUAL, AS 1100 00:36:48,997 --> 00:36:52,100 WELL AS THE IMPORTANCE OF 1101 00:36:52,100 --> 00:36:52,934 OFFSPRING CARDIOVASCULAR HEALTH 1102 00:36:52,934 --> 00:36:56,004 WHICH HAS ALSO BEEN DEMONSTRATED 1103 00:36:56,004 --> 00:36:57,338 IN OBSERVATIONAL COHORT STUDIES. 1104 00:36:57,338 --> 00:36:59,073 WE WANTED TO FOCUS ON SOME OF 1105 00:36:59,073 --> 00:37:01,075 THE FOUNDATIONAL DETERMINANTS OF 1106 00:37:01,075 --> 00:37:02,944 CARDIOVASCULAR HEALTH WITHIN 1107 00:37:02,944 --> 00:37:04,245 THIS STATEMENT, PARTICULARLY 1108 00:37:04,245 --> 00:37:05,346 WITH THE IMPORTANCE OF STRESS 1109 00:37:05,346 --> 00:37:06,814 AND RESILIENCE, SOCIAL DETERMINE 1110 00:37:06,814 --> 00:37:08,316 NANCE AND STRUCTURAL POLICIES 1111 00:37:08,316 --> 00:37:09,484 THAT ALL NEED TO BE APPROACHED 1112 00:37:09,484 --> 00:37:12,053 IF WE ARE GOING TO OPTIMIZE 1113 00:37:12,053 --> 00:37:13,354 CARDIOVASCULAR HEALTH BROADLY IN 1114 00:37:13,354 --> 00:37:14,556 PREGNANT AND POSTPARTUM 1115 00:37:14,556 --> 00:37:19,360 INDIVIDUALS AND OFFSPRING. 1116 00:37:19,360 --> 00:37:22,897 ONE OF THE THINGS THAT REPEATED 1117 00:37:22,897 --> 00:37:24,332 MEASUREMENTS IN COHORTS IS 1118 00:37:24,332 --> 00:37:25,767 HIGHLIGHTED WITH CARDIOVASCULAR 1119 00:37:25,767 --> 00:37:27,535 HEALTH IS THE YOUNG ADULT PERIOD 1120 00:37:27,535 --> 00:37:29,971 OR THE REPRODUCTIVE YEARS, OFTEN 1121 00:37:29,971 --> 00:37:32,273 SHOW CRITICAL PERIODS OF DECLINE 1122 00:37:32,273 --> 00:37:33,841 IN CARDIOVASCULAR HEALTH. 1123 00:37:33,841 --> 00:37:35,743 SHOWN IN THE FIRST PANEL HERE 1124 00:37:35,743 --> 00:37:37,078 ARE CLINICAL CARDIOVASCULAR 1125 00:37:37,078 --> 00:37:39,013 HEALTH SCORES FROM FIVE 1126 00:37:39,013 --> 00:37:40,815 POPULATION-BASED COHORTS THAT 1127 00:37:40,815 --> 00:37:42,250 IDENTIFIED FIVE DIFFERENT 1128 00:37:42,250 --> 00:37:44,452 TRAJECTORIES SHOWING OVERALL 1129 00:37:44,452 --> 00:37:46,087 DECLINE WITH SOME MORE RAPID 1130 00:37:46,087 --> 00:37:47,989 DECLINE THAN OTHERS, BUT REALLY 1131 00:37:47,989 --> 00:37:49,090 HIGHLIGHTING THIS PERIOD OF TIME 1132 00:37:49,090 --> 00:37:51,059 IN YOUNG ADULTHOOD. 1133 00:37:51,059 --> 00:37:54,295 IN AN OLDER STUDY FROM THE NGHS, 1134 00:37:54,295 --> 00:37:57,065 SHOWN HERE ARE CARDIOVASCULAR 1135 00:37:57,065 --> 00:37:59,534 HEALTH PROFILES FROM OVER 2,000 1136 00:37:59,534 --> 00:38:01,536 INDIVIDUALS AGED 9 TO 19 THAT 1137 00:38:01,536 --> 00:38:03,504 WERE FOLLOWED ANNUALLY FOR THAT 1138 00:38:03,504 --> 00:38:04,839 PERIOD OF TIME, AND AGAIN, WE 1139 00:38:04,839 --> 00:38:08,376 SEE A SIMILAR PATTERN OF VARYING 1140 00:38:08,376 --> 00:38:09,611 CARDIOVASCULAR HEALTH DECLINE, 1141 00:38:09,611 --> 00:38:12,013 WHERE AN INDIVIDUAL STARTED MAY 1142 00:38:12,013 --> 00:38:13,982 INFORM WHERE THEY END UP, BUT 1143 00:38:13,982 --> 00:38:15,450 STILL DIFFERING PATTERNS OVER 1144 00:38:15,450 --> 00:38:16,851 THIS TIME PERIOD. 1145 00:38:16,851 --> 00:38:18,286 ONE OF THE MOST IMPORTANT 1146 00:38:18,286 --> 00:38:23,057 PRETICK TORES AND WHO 1147 00:38:23,057 --> 00:38:24,592 PREDICTORS AND WHO HAD THE MOST 1148 00:38:24,592 --> 00:38:26,494 DECLINE IN TEENAGE GIRLS WAS THE 1149 00:38:26,494 --> 00:38:27,362 INCIDENCE OF PREGNANCY. 1150 00:38:27,362 --> 00:38:28,696 SO THIS WAS REALLY HIGHLIGHTING 1151 00:38:28,696 --> 00:38:30,798 THAT PREGNANCY CAN BE AN 1152 00:38:30,798 --> 00:38:32,667 INFLECTION POINT, UNFORTUNATELY 1153 00:38:32,667 --> 00:38:34,235 FOR WORSENING CARDIOVASCULAR 1154 00:38:34,235 --> 00:38:36,170 HEALTH BUT ALSO IDENTIFIES AN 1155 00:38:36,170 --> 00:38:37,639 OPPORTUNITY FOR TARGETING 1156 00:38:37,639 --> 00:38:39,040 CARDIOVASCULAR HEALTH DURING 1157 00:38:39,040 --> 00:38:42,443 THIS CRITICAL PERIOD. 1158 00:38:42,443 --> 00:38:44,646 BUT GAPS EXIST THAT PREVENT 1159 00:38:44,646 --> 00:38:46,214 IDEAL CARDIOVASCULAR HEALTH FOR 1160 00:38:46,214 --> 00:38:46,981 BIRTHING INDIVIDUALS AND I 1161 00:38:46,981 --> 00:38:48,716 WANTED TO HIGHLIGHT THESE FOUR 1162 00:38:48,716 --> 00:38:49,951 AREAS. 1163 00:38:49,951 --> 00:38:51,519 FIRST, AWARENESS OF 1164 00:38:51,519 --> 00:38:53,288 CARDIOVASCULAR DISEASE RISK BY 1165 00:38:53,288 --> 00:38:54,555 INDIVIDUALS THEMSELVES, AS WELL 1166 00:38:54,555 --> 00:38:55,556 AS CLINICIANS. 1167 00:38:55,556 --> 00:38:58,126 AND FOLLOWING THAT, AWARENESS OF 1168 00:38:58,126 --> 00:38:59,894 ADVERSE PREGNANCY OUTCOMES AS 1169 00:38:59,894 --> 00:39:01,095 CARDIOVASCULAR DISEASE RISK 1170 00:39:01,095 --> 00:39:02,063 ENHANCERS. 1171 00:39:02,063 --> 00:39:04,666 IN ORDER TO BETTER ESTIMATE 1172 00:39:04,666 --> 00:39:08,036 RISK, ENSURING THAT 1173 00:39:08,036 --> 00:39:10,204 CARDIOVASCULAR RISK PREDICTION 1174 00:39:10,204 --> 00:39:11,506 TOOLS ARE AVAILABLE FOR ADULTS 1175 00:39:11,506 --> 00:39:14,008 AND ENSURING WE DO THIS IN THE 1176 00:39:14,008 --> 00:39:15,209 CONTEXT OF SOCIAL AND STRUCTURAL 1177 00:39:15,209 --> 00:39:16,177 FACTORS SUCH AS SOCIAL 1178 00:39:16,177 --> 00:39:19,080 DETERMINANTS OF HEALTH. 1179 00:39:19,080 --> 00:39:20,515 MANY OF YOU ARE PROBABLY 1180 00:39:20,515 --> 00:39:21,816 FAMILIAR WITH THESE DATA THAT 1181 00:39:21,816 --> 00:39:23,284 ARE HIGHLIGHTED FROM THE 1182 00:39:23,284 --> 00:39:26,254 AMERICAN HEART ASSOCIATION THAT 1183 00:39:26,254 --> 00:39:27,989 DEMONSTRATED THAT THERE IS AN 1184 00:39:27,989 --> 00:39:29,190 UNDERAPPRECIATION OR 1185 00:39:29,190 --> 00:39:30,458 UNDERAWARENESS BY INDIVIDUALS 1186 00:39:30,458 --> 00:39:32,460 FOR THE LEADING CAUSE OF DEATH 1187 00:39:32,460 --> 00:39:39,233 AMONG WOMEN -- HEART DISEASE. 1188 00:39:39,233 --> 00:39:40,335 REPORTED THAT HEART DISEASE WAS 1189 00:39:40,335 --> 00:39:41,402 THEIR LEADING CAUSE OF DEATH, 1190 00:39:41,402 --> 00:39:44,706 THIS DROPPED TO BELOW 50%. 1191 00:39:44,706 --> 00:39:47,475 IN A SURVEY LED AT OUR CENTER, 1192 00:39:47,475 --> 00:39:49,410 WE SURVEYED 700 POSTPARTUM 1193 00:39:49,410 --> 00:39:52,347 PEOPLE AND ONLY ABOUT 50% OF 1194 00:39:52,347 --> 00:39:53,548 INDIVIDUALS WHO HAD EXPERIENCED 1195 00:39:53,548 --> 00:39:55,116 AN ADVERSE PREGNANCY OUTCOME 1196 00:39:55,116 --> 00:39:56,584 RECOGNIZED THAT THEIR 1197 00:39:56,584 --> 00:39:58,319 CARDIOVASCULAR DISEASE RISK WAS 1198 00:39:58,319 --> 00:39:59,187 HIGHER THAN AVERAGE. 1199 00:39:59,187 --> 00:40:00,988 AND WE'VE SEEN SIMILAR STUDIES 1200 00:40:00,988 --> 00:40:03,491 FROM OTHER CENTERS AS WELL AS 1201 00:40:03,491 --> 00:40:06,027 FROM A CLINICAL PER EXECUTIVE OF 1202 00:40:06,027 --> 00:40:07,028 CLINICIANS NOT BEING AWARE OF 1203 00:40:07,028 --> 00:40:10,665 THIS RISK AS WELL. 1204 00:40:10,665 --> 00:40:12,834 WE ALSO KNOW THAT THERE ARE GAPS 1205 00:40:12,834 --> 00:40:13,835 IN CARDIOVASCULAR DISEASE 1206 00:40:13,835 --> 00:40:15,403 GUIDELINES AFTER AN ADVERSE 1207 00:40:15,403 --> 00:40:16,070 PREGNANCY OUTCOME. 1208 00:40:16,070 --> 00:40:17,739 WHILE THE 2019 PRIMARY 1209 00:40:17,739 --> 00:40:19,140 PREVENTION GUIDELINES RECOMMEND 1210 00:40:19,140 --> 00:40:21,576 RISK ASSESSMENT WITH THE POOLED 1211 00:40:21,576 --> 00:40:23,010 COHORT EQUATIONS AND HIGHLIGHT 1212 00:40:23,010 --> 00:40:24,212 ADVERSE PREGNANCY OUTCOMES AS 1213 00:40:24,212 --> 00:40:25,446 RISK ENHANCING FACTORS, THERE 1214 00:40:25,446 --> 00:40:26,948 ARE NO SPECIFIC RECOMMENDATIONS 1215 00:40:26,948 --> 00:40:28,816 FOR THOSE WHO EXPERIENCE AN 1216 00:40:28,816 --> 00:40:32,687 ADVERSE PREGNANCY OUT COME. 1217 00:40:32,687 --> 00:40:34,355 IN FACT, CURRENT RECOMMENDATIONS 1218 00:40:34,355 --> 00:40:37,592 FOR YOUNG ADULTS ALSO FOCUS ON 1219 00:40:37,592 --> 00:40:39,794 RISK ASSESSMENT WITH 30-YEAR 1220 00:40:39,794 --> 00:40:43,164 RISK BUT THE POOLED COHORT 1221 00:40:43,164 --> 00:40:45,433 EQUATIONS BEGIN AT AGE 40. 1222 00:40:45,433 --> 00:40:47,402 ONE WAY WE WERE ABLE TO RECENTLY 1223 00:40:47,402 --> 00:40:48,903 ADDRESS THIS WAS WITH A 1224 00:40:48,903 --> 00:40:51,072 DEVELOPMENT AND VALIDATION OF 1225 00:40:51,072 --> 00:40:53,241 THE 2023 PREDICTING RISK IN 1226 00:40:53,241 --> 00:40:54,342 CARDIOVASCULAR DISEASE EQUATIONS 1227 00:40:54,342 --> 00:40:56,043 OR THE PREVENT EQUATIONS WHICH 1228 00:40:56,043 --> 00:40:58,913 NOW ENABLE RISK CALCULATION AT 1229 00:40:58,913 --> 00:41:01,182 AGE 30 AND INCLUDE 10-YEAR AND 1230 00:41:01,182 --> 00:41:06,421 30-YEAR RISK ESTIMATION. 1231 00:41:06,421 --> 00:41:08,790 AS WE SAID PORPLY, ASSESSING AND 1232 00:41:08,790 --> 00:41:09,557 ADDRESSING SOCIAL DETERMINANTS 1233 00:41:09,557 --> 00:41:10,658 OF HEALTH WHICH ARE THE 1234 00:41:10,658 --> 00:41:12,059 FUNDAMENTAL CAUSES OF HEALTH 1235 00:41:12,059 --> 00:41:14,328 INEQUITY ARE NEEDED. 1236 00:41:14,328 --> 00:41:18,699 AND A VERY, I THINK, POINTED 1237 00:41:18,699 --> 00:41:20,601 QUOTE FROM KAREN JOINT MADDOX 1238 00:41:20,601 --> 00:41:22,069 I'VE HEARD BEFORE WHICH I THINK 1239 00:41:22,069 --> 00:41:23,471 IS HIGHLY RELEVANT HERE IS THAT 1240 00:41:23,471 --> 00:41:24,572 STRUCTURAL PROBLEMS REQUIRE 1241 00:41:24,572 --> 00:41:25,606 STRUCTURAL SOLUTIONS, SO BEING 1242 00:41:25,606 --> 00:41:27,508 ABLE TO FOCUS ON THIS AS WE MOVE 1243 00:41:27,508 --> 00:41:32,313 FORWARD IS CRITICAL. 1244 00:41:32,313 --> 00:41:34,215 SO WHAT ABOUT QUESTIONS THAT ARE 1245 00:41:34,215 --> 00:41:34,515 UNANSWERED? 1246 00:41:34,515 --> 00:41:36,217 AND HOW DO WE FILL THESE GAPS 1247 00:41:36,217 --> 00:41:36,751 THAT EXIST? 1248 00:41:36,751 --> 00:41:39,220 AND IF WE FOCUS ON MEASURING AND 1249 00:41:39,220 --> 00:41:40,655 MODIFYING CARDIOVASCULAR HEALTH, 1250 00:41:40,655 --> 00:41:42,690 I'M GOING TO CONCLUDE WITH FOUR 1251 00:41:42,690 --> 00:41:43,958 KEY QUESTIONS. 1252 00:41:43,958 --> 00:41:45,893 HOW SHOULD WE MONITOR AND TREAT 1253 00:41:45,893 --> 00:41:47,495 BLOOD PRESSURE AS A KEY TARGET 1254 00:41:47,495 --> 00:41:49,230 IN THE POSTPARTUM PERIOD? 1255 00:41:49,230 --> 00:41:51,999 WHAT ARE THE PATHWAYS, 1256 00:41:51,999 --> 00:41:53,568 PREDICTORS AND MEDIATORS TO 1257 00:41:53,568 --> 00:41:54,435 CLINICAL CARDIOVASCULAR DISEASE? 1258 00:41:54,435 --> 00:41:56,404 HOW DO WE INTEGRATE THE NEW 1259 00:41:56,404 --> 00:41:58,539 CONSTRUCT OF CARDIOVASCULAR 1260 00:41:58,539 --> 00:41:59,674 KIDNEY METABOLIC HEALTH THAT THE 1261 00:41:59,674 --> 00:42:01,142 AMERICAN HEART ASSOCIATION 1262 00:42:01,142 --> 00:42:02,643 RECENTLY RELEASED THAT BUILDS ON 1263 00:42:02,643 --> 00:42:04,779 THE CONCEPT OF LIFE'S ESSENTIAL 1264 00:42:04,779 --> 00:42:06,581 EIGHT AND CARDIOVASCULAR HEALTH, 1265 00:42:06,581 --> 00:42:08,883 AND LOW DO WE DESIGN MULTILEVEL 1266 00:42:08,883 --> 00:42:10,551 INTERVENTIONS FOR CARDIOVASCULAR 1267 00:42:10,551 --> 00:42:12,753 HEALTH EQUITY. 1268 00:42:12,753 --> 00:42:14,856 IN TERMS OF WHEN AND HOW TO 1269 00:42:14,856 --> 00:42:16,123 TREAT BLOOD PRESSURE POSTPARTUM, 1270 00:42:16,123 --> 00:42:18,493 THERE ARE LIMITED DATA IN BLOOD 1271 00:42:18,493 --> 00:42:19,927 PRESSURE DURING PREGNANCY AND 1272 00:42:19,927 --> 00:42:21,562 POSTPARTUM THAT HAVE FOLLOWED 1273 00:42:21,562 --> 00:42:23,197 INDIVIDUALS THROUGHOUT THESE TWO 1274 00:42:23,197 --> 00:42:23,764 TIME PERIODS. 1275 00:42:23,764 --> 00:42:26,467 AND THIS IS SOME DATA THAT SHOW 1276 00:42:26,467 --> 00:42:27,768 THAT INDIVIDUALS WHO HAVE A 1277 00:42:27,768 --> 00:42:28,870 HYPERTENSIVE DISORDER OF 1278 00:42:28,870 --> 00:42:30,471 PREGNANCY MAY FOLLOW TWO 1279 00:42:30,471 --> 00:42:31,672 DIFFERENT TRAJECTORIES. 1280 00:42:31,672 --> 00:42:33,174 SOME REMAIN ELEVATED AND SOME 1281 00:42:33,174 --> 00:42:34,242 RETURN BACK TO NORMAL. 1282 00:42:34,242 --> 00:42:36,878 BUT HOW DO WE KNOW WHO ENDS IN 1283 00:42:36,878 --> 00:42:38,279 WHICH GROUP AND HOW TO TREAT 1284 00:42:38,279 --> 00:42:41,883 THEM BEST? 1285 00:42:41,883 --> 00:42:46,721 IN AN R34 FUNDED BY NHLBI, THIS 1286 00:42:46,721 --> 00:42:49,290 QUESTION IS BEING STUDIED IN A 1287 00:42:49,290 --> 00:42:50,925 PILOT STUDY TO LOOK AT MORE 1288 00:42:50,925 --> 00:42:52,493 INTENSIVE AND LESS INTENSIVE 1289 00:42:52,493 --> 00:42:56,030 BLOOD PRESSURE CONTROL IN EARLY 1290 00:42:56,030 --> 00:42:56,330 POSTPARTUM. 1291 00:42:56,330 --> 00:42:57,331 AND STARTING TO ADDRESS THIS 1292 00:42:57,331 --> 00:42:59,200 QUESTION OF WHAT ARE THE OPTIMAL 1293 00:42:59,200 --> 00:43:00,434 BLOOD PRESSURE GOALS AFTER 1294 00:43:00,434 --> 00:43:01,969 HYPERTENSIVE DISORDERS IN THE 1295 00:43:01,969 --> 00:43:03,504 POSTPARTUM PERIOD, AND HOW EARLY 1296 00:43:03,504 --> 00:43:06,908 SHOULD INTERVENTIONS BEGIN? 1297 00:43:06,908 --> 00:43:08,409 I THINK AS WE THINK ABOUT THESE 1298 00:43:08,409 --> 00:43:09,310 QUESTIONS, OTHER RELATED 1299 00:43:09,310 --> 00:43:12,146 QUESTIONS THAT WE NEED TO BETTER 1300 00:43:12,146 --> 00:43:13,214 UNDERSTAND INCLUDE HOW DO WE 1301 00:43:13,214 --> 00:43:15,149 SUPPORT AND SUPPLEMENT 1302 00:43:15,149 --> 00:43:17,351 ANTIHYPERTENSIVE THERAPY WITH 1303 00:43:17,351 --> 00:43:17,985 LIFESTYLE, BEHAVIORAL 1304 00:43:17,985 --> 00:43:20,288 INTERVENTIONS IN THIS PERIOD? 1305 00:43:20,288 --> 00:43:21,556 SHOULD ASPIRIN OR STATINS BE 1306 00:43:21,556 --> 00:43:22,757 USED IN THIS PERIOD? 1307 00:43:22,757 --> 00:43:25,059 OR IN THE SHORT TERM AFTER A 1308 00:43:25,059 --> 00:43:25,826 HYPERTENSIVE DISORDER OF 1309 00:43:25,826 --> 00:43:27,995 PREGNANCY? 1310 00:43:27,995 --> 00:43:29,263 AND SHOULD WE TARGET 1311 00:43:29,263 --> 00:43:30,131 INTERVENTIONS EVEN AMONG THOSE 1312 00:43:30,131 --> 00:43:32,333 WHO DON'T EXPERIENCE A 1313 00:43:32,333 --> 00:43:33,601 HYPERTENSIVE DISORDER BUT HAVE 1314 00:43:33,601 --> 00:43:37,772 ELEVATED BLOOD PRESSURE ALONE? 1315 00:43:37,772 --> 00:43:39,307 SECOND IS HOW DO WE DEFINE THE 1316 00:43:39,307 --> 00:43:41,676 PATHWAYS AND MECHANISMS IN THE 1317 00:43:41,676 --> 00:43:42,343 PERIPARTUM PERIOD? 1318 00:43:42,343 --> 00:43:44,312 WE KNOW THAT CLINICAL 1319 00:43:44,312 --> 00:43:45,379 CARDIOVASCULAR DISEASE OFTEN 1320 00:43:45,379 --> 00:43:47,315 OCCURS IN THE SIXTH DECADE OF 1321 00:43:47,315 --> 00:43:49,083 LIFE BUT THE ORIGINS OF DISEASE 1322 00:43:49,083 --> 00:43:51,686 BEGIN MUCH EARLIER. 1323 00:43:51,686 --> 00:43:53,521 AUTOPSY STUDIES HIGHLIGHT BY THE 1324 00:43:53,521 --> 00:43:55,289 SECOND DECADE OF LIKE, THERE ARE 1325 00:43:55,289 --> 00:43:58,125 PLAQUES ALREADY DEVELOPING AND 1326 00:43:58,125 --> 00:43:59,994 PROGRESSING EVEN AS EARLY AS AGE 1327 00:43:59,994 --> 00:44:02,129 20s AND 30s WHEN PEOPLE MAY 1328 00:44:02,129 --> 00:44:03,664 BE BECOMING PREGNANT. 1329 00:44:03,664 --> 00:44:05,733 SO SUBCLINICAL MEASURES OF 1330 00:44:05,733 --> 00:44:06,867 CARDIOVASCULAR DISEASE WITH 1331 00:44:06,867 --> 00:44:07,602 ULTRASOUND SPECIFICALLY CAN BE 1332 00:44:07,602 --> 00:44:11,405 VERY USEFUL, AND IN THIS 1333 00:44:11,405 --> 00:44:14,075 R01 FUNDED BY NHLBI, WHICH IS 1334 00:44:14,075 --> 00:44:15,409 ANCILLARY TO THE NEW MOM TO BE 1335 00:44:15,409 --> 00:44:17,378 HEART HEALTH STUDY, WE'RE 1336 00:44:17,378 --> 00:44:19,113 CURRENTLY DOING CAROTID 1337 00:44:19,113 --> 00:44:22,683 ULTRASOUND TO LOOK AT VASCULAR 1338 00:44:22,683 --> 00:44:24,552 INJURY AS WELL AS THICKNESS TO 1339 00:44:24,552 --> 00:44:25,753 BETTER UNDERSTAND THE PATHWAYS 1340 00:44:25,753 --> 00:44:27,388 FROM EARLY PREG SEAL WHEN THESE 1341 00:44:27,388 --> 00:44:29,824 INDIVIDUALS WERE FIRST RECRUITED 1342 00:44:29,824 --> 00:44:33,894 TO RIGOROUS ADJUDICATION OF 1343 00:44:33,894 --> 00:44:36,631 PREGNANCY OUTCOMES AND FOLLOW-UP 1344 00:44:36,631 --> 00:44:38,532 MEASURES ABOUT 10 YEARS DO DOWNE 1345 00:44:38,532 --> 00:44:41,602 ROAD. 1346 00:44:41,602 --> 00:44:43,371 THIRD, THIS QUESTION OF HOW DO 1347 00:44:43,371 --> 00:44:45,339 WE BROADEN AND THINK ABOUT MORE 1348 00:44:45,339 --> 00:44:47,041 INCLUSIVELY KIDNEY HEALTH, 1349 00:44:47,041 --> 00:44:48,242 METABOLIC HEALTH AND 1350 00:44:48,242 --> 00:44:49,577 CARDIOVASCULAR DISEASE RISK FOR 1351 00:44:49,577 --> 00:44:51,979 THE PREGNANT AND POSTPARTUM 1352 00:44:51,979 --> 00:44:52,413 INDIVIDUAL? 1353 00:44:52,413 --> 00:44:55,082 LAST YEAR THE AHA RELEASED THIS 1354 00:44:55,082 --> 00:44:56,050 PRESIDENTIAL ADVISORY WHICH I 1355 00:44:56,050 --> 00:44:57,351 WAS FORTUNATE TO WORK WITH THIS 1356 00:44:57,351 --> 00:44:59,654 AMAZING TEAM ON DEFINING 1357 00:44:59,654 --> 00:45:01,155 CARDIOVASCULAR KIDNEY METABOLIC 1358 00:45:01,155 --> 00:45:02,356 SYNDROME AS A HEALTH DISORDER 1359 00:45:02,356 --> 00:45:04,191 DUE TO CONNECTIONS AMONG HEART 1360 00:45:04,191 --> 00:45:05,693 DISEASE, KIDNEY DISEASE, 1361 00:45:05,693 --> 00:45:08,229 DIABETES AND OBESITY LEADING TO 1362 00:45:08,229 --> 00:45:09,864 POOR HEALTH OUTCOMES, NOTINGLY 1363 00:45:09,864 --> 00:45:11,799 WE INCLUDED GESTATIONAL DIABETES 1364 00:45:11,799 --> 00:45:12,900 AND HYPERTENSIVE DISORDERS OF 1365 00:45:12,900 --> 00:45:14,068 PREGNANCY WITHIN THE FRAMEWORK, 1366 00:45:14,068 --> 00:45:15,469 BUT I THINK ONE THING THAT WE 1367 00:45:15,469 --> 00:45:16,837 REALLY NEED TO BUILD ON AS WE 1368 00:45:16,837 --> 00:45:19,106 THINK ABOUT THE PERIPARTUM 1369 00:45:19,106 --> 00:45:21,842 PERIOD IS HOW DO WE INTEGRATE 1370 00:45:21,842 --> 00:45:23,244 THE STAGING INTO THIS POPULATION 1371 00:45:23,244 --> 00:45:27,281 FOR DELIVERY OF CARE. 1372 00:45:27,281 --> 00:45:29,450 LAST, HOW DO WE THINK ABOUT THE 1373 00:45:29,450 --> 00:45:31,485 WHOLE PICTURE WITHIN A 1374 00:45:31,485 --> 00:45:32,586 SOCIOECOLOGICAL FRAMEWORK THAT 1375 00:45:32,586 --> 00:45:34,789 LOOKS AT POLICIES, COMMUNITY 1376 00:45:34,789 --> 00:45:36,323 ENGAGED INTERVENTIONS, HEALTH 1377 00:45:36,323 --> 00:45:37,625 SYSTEM BASED INTERVENTIONS AS 1378 00:45:37,625 --> 00:45:39,694 WELL AS THE INDIVIDUAL PATIENT 1379 00:45:39,694 --> 00:45:40,027 CLINICIAN. 1380 00:45:40,027 --> 00:45:41,462 SHOWN HERE ARE SOME EXAMPLES OF 1381 00:45:41,462 --> 00:45:43,230 POLICIES THAT COULD BE 1382 00:45:43,230 --> 00:45:44,165 CONSIDERED AND ARE CURRENTLY 1383 00:45:44,165 --> 00:45:45,766 BEING CONSIDERED INCLUDING 1384 00:45:45,766 --> 00:45:47,268 POSTPARTUM MEDICAID EXTENSION 1385 00:45:47,268 --> 00:45:49,236 AND SMOKING BANS, THINKING ABOUT 1386 00:45:49,236 --> 00:45:51,505 COMMUNITY ENGAGED INTERVENTIONS, 1387 00:45:51,505 --> 00:45:52,940 TARGETING CHURCH-BASED 1388 00:45:52,940 --> 00:45:54,675 INTERVENTIONS AND BARBERSHOP 1389 00:45:54,675 --> 00:45:55,776 INTERVENTIONS FOR LOWERING BLOOD 1390 00:45:55,776 --> 00:45:56,744 PRESSURE, HEALTH SYSTEM 1391 00:45:56,744 --> 00:46:01,782 INTERVENTIONS LIKE REMOTE PLOOPD 1392 00:46:01,782 --> 00:46:06,287 PRESSURE MONITORING AND AT THE 1393 00:46:06,287 --> 00:46:07,388 INDIVIDUAL CLINICIAN-PATIENT 1394 00:46:07,388 --> 00:46:07,588 LEVEL. 1395 00:46:07,588 --> 00:46:09,156 ONE OF THE PROJECTS THAT I AM 1396 00:46:09,156 --> 00:46:12,259 REALLY EXCITED TO BE WORKING ON 1397 00:46:12,259 --> 00:46:14,795 WITH DR. CHARLOTTE PRATT FROM 1398 00:46:14,795 --> 00:46:16,097 NHLBI AS WELL AS DR. PRICE AND 1399 00:46:16,097 --> 00:46:17,598 DR. DONZE AND MANY OTHERS IS THE 1400 00:46:17,598 --> 00:46:19,033 ENRICH STUDY, THE EARLY 1401 00:46:19,033 --> 00:46:20,234 INTERVENTION TO PROMOTE 1402 00:46:20,234 --> 00:46:21,435 CARDIOVASCULAR HEALTH OF MOTHERS 1403 00:46:21,435 --> 00:46:22,803 AND CHILDREN. 1404 00:46:22,803 --> 00:46:23,804 SHOWN HERE ARE THE SITES THAT 1405 00:46:23,804 --> 00:46:26,207 ARE INVOLVED IN THE ENRICH 1406 00:46:26,207 --> 00:46:28,509 PROJECT, AND IF WE GO BACK A 1407 00:46:28,509 --> 00:46:29,910 SLIDE, JUST HIGHLIGHTING SOME OF 1408 00:46:29,910 --> 00:46:32,513 THE KEY INNOVATIONS OF ENRICH 1409 00:46:32,513 --> 00:46:35,583 INCLUDE THE APPROACH USING 1410 00:46:35,583 --> 00:46:36,584 EVIDENCE-BASED -- TO LEVERAGE 1411 00:46:36,584 --> 00:46:38,119 EXISTING SETTINGS WHERE FAMILIES 1412 00:46:38,119 --> 00:46:40,621 WHO HAVE ADVERSE SOCIAL FACTORS 1413 00:46:40,621 --> 00:46:42,623 ARE ALREADY RECEIVING CARE TO 1414 00:46:42,623 --> 00:46:44,325 ALLOW A SCALABLE APPROACH WITH A 1415 00:46:44,325 --> 00:46:46,627 FOCUS ON HEALTH EQUITY. 1416 00:46:46,627 --> 00:46:48,896 THE ENRICH STUDIES ALSO FOCUSING 1417 00:46:48,896 --> 00:46:50,331 ON TWO GENERATIONS, BOTH PARENT 1418 00:46:50,331 --> 00:46:54,168 AND CHILD, THAT UNIQUELY WILL 1419 00:46:54,168 --> 00:46:55,703 EXAMINE AN INTERVENTION AND 1420 00:46:55,703 --> 00:46:58,205 MEASURE CVH IN A REMOTE 1421 00:46:58,205 --> 00:47:01,375 DECENTRALIZED TRIAL DESIGN. 1422 00:47:01,375 --> 00:47:02,810 SO I WANT TO SUMMARIZE WHAT 1423 00:47:02,810 --> 00:47:04,345 WE'VE TALKED ABOUT WITH THREE 1424 00:47:04,345 --> 00:47:07,948 KEY TAKEAWAYS. 1425 00:47:07,948 --> 00:47:10,651 THE REPRODUCTIVE LIFE COURSE 1426 00:47:10,651 --> 00:47:11,852 FRAMEWORK OR THAT CONCEPTUAL 1427 00:47:11,852 --> 00:47:13,621 FIGURE WE USE HIGHLIGHTS THE 1428 00:47:13,621 --> 00:47:15,022 PERIPARTUM PERIOD AS A WINDOW OF 1429 00:47:15,022 --> 00:47:17,224 OPPORTUNITY WHEN RISK FOR 1430 00:47:17,224 --> 00:47:19,226 CARDIOVASCULAR DISEASE IS 1431 00:47:19,226 --> 00:47:19,727 UNMASKED. 1432 00:47:19,727 --> 00:47:21,028 SECOND, WE LOOKED AT SECULAR 1433 00:47:21,028 --> 00:47:22,797 TRENDS SHOWING POPULATION LEVEL 1434 00:47:22,797 --> 00:47:24,198 DECLINES IN OPTIMAL 1435 00:47:24,198 --> 00:47:25,299 CARDIOVASCULAR HEALTH AS REALLY 1436 00:47:25,299 --> 00:47:28,235 THE MAJOR DRIVER OF ADVERSE 1437 00:47:28,235 --> 00:47:29,637 TRENDS AND ADVERSE PREGNANCY 1438 00:47:29,637 --> 00:47:30,971 OUTCOMES EVEN IN YOUNGER 1439 00:47:30,971 --> 00:47:33,040 GENERATIONS AND PARTICULARLY IN 1440 00:47:33,040 --> 00:47:34,875 YOUNGER GENERATIONS WITH 1441 00:47:34,875 --> 00:47:36,076 PERSISTENT RACIAL AND ETHNIC 1442 00:47:36,076 --> 00:47:36,510 DISPARITIES. 1443 00:47:36,510 --> 00:47:39,046 AND THIRD, A SHIFT TOWARDS 1444 00:47:39,046 --> 00:47:40,748 GENERATING AND IMPLENTYING 1445 00:47:40,748 --> 00:47:42,716 EVIDENCE BASE TO MEASURE, MODIFY 1446 00:47:42,716 --> 00:47:44,919 AND MONITOR CVH AND PERHAPS NOW 1447 00:47:44,919 --> 00:47:47,288 MORE BROADLY CARDIOVASCULAR 1448 00:47:47,288 --> 00:47:47,955 KIDNEY METABOLIC HEALTH IS 1449 00:47:47,955 --> 00:47:51,892 NEEDED TO ACHIEVE HEALTH EQUITY. 1450 00:47:51,892 --> 00:47:54,161 SO I'M GOING TO END WITH THE 1451 00:47:54,161 --> 00:47:55,462 ANALOGY THAT WE STARTED WITH IN 1452 00:47:55,462 --> 00:47:57,331 TERMS OF PREGNANCY AS A WINDOW 1453 00:47:57,331 --> 00:47:59,700 TO FUTURE CARDIOVASCULAR HEALTH 1454 00:47:59,700 --> 00:48:01,502 AND PROPOSE THAT WE THINK ABOUT 1455 00:48:01,502 --> 00:48:03,871 THE FULL PERIPARTUM SPECTRUM AS 1456 00:48:03,871 --> 00:48:05,206 OUR IDEAL WINDOWS OF OPPORTUNITY 1457 00:48:05,206 --> 00:48:07,474 TO IMPROVE CARDIOVASCULAR HEALTH 1458 00:48:07,474 --> 00:48:09,243 AND CARDIOVASCULAR KIDNEY 1459 00:48:09,243 --> 00:48:15,282 METABOLIC HEALTH. 1460 00:48:15,282 --> 00:48:15,549 WONDERFUL. 1461 00:48:15,549 --> 00:48:17,451 THANK YOU SO MUCH FOR YOUR TIME 1462 00:48:17,451 --> 00:48:19,019 AND ATTENTION, AND LOOK FORWARD 1463 00:48:19,019 --> 00:48:26,260 TO THE DISCUSSION AND Q & A. 1464 00:48:26,260 --> 00:48:26,961 >> WONDERFUL. 1465 00:48:26,961 --> 00:48:28,529 THANK YOU, DR. KHAN, FOR YOUR 1466 00:48:28,529 --> 00:48:30,798 EXCELLENT PRESENTATION. 1467 00:48:30,798 --> 00:48:33,634 THIS IS A VERY TIMELY TOPIC 1468 00:48:33,634 --> 00:48:36,370 ESPECIALLY IN WITH THE INCREASE 1469 00:48:36,370 --> 00:48:37,671 OF ADVERSE PREGNANCIES IN RECENT 1470 00:48:37,671 --> 00:48:38,873 YEARS SO I'M VERY EXCITE TODAY 1471 00:48:38,873 --> 00:48:39,406 HAVE THIS DISCUSSION. 1472 00:48:39,406 --> 00:48:40,608 I WOULD LIKE TO REMIND THE 1473 00:48:40,608 --> 00:48:43,577 AUDIENCE TO PLEASE EMAIL YOUR 1474 00:48:43,577 --> 00:48:47,514 QUESTIONS TO ONPA@MAIL.NIH.GOV, 1475 00:48:47,514 --> 00:48:48,916 OR YOU CAN SUBMIT THEM THROUGH 1476 00:48:48,916 --> 00:48:52,820 THE LIVE FEEDBACK IN THE 1477 00:48:52,820 --> 00:48:54,154 VIDEOCAST. 1478 00:48:54,154 --> 00:48:55,689 AS THE QUESTIONS ARE COMING IN, 1479 00:48:55,689 --> 00:48:58,092 DR. KHAN, I WOULD LIKE TO 1480 00:48:58,092 --> 00:48:59,093 PROPOSE -- OR POSE ONE QUESTION 1481 00:48:59,093 --> 00:48:59,860 TO YOU. 1482 00:48:59,860 --> 00:49:03,797 SO FIRST I REALLY LOVE THAT YOU 1483 00:49:03,797 --> 00:49:05,165 DISCUSSED THE -- OR AT LEAST 1484 00:49:05,165 --> 00:49:07,768 MENTIONED THE MENOPAUSAL AND 1485 00:49:07,768 --> 00:49:08,769 POST-MENOPAUSAL PERIODS AS A 1486 00:49:08,769 --> 00:49:10,838 PART OF THE POSTPARTUM PHASE OF 1487 00:49:10,838 --> 00:49:11,438 A WOMAN'S LIFE. 1488 00:49:11,438 --> 00:49:12,840 I THINK WE OFTEN DON'T THINK 1489 00:49:12,840 --> 00:49:14,174 ABOUT THAT. 1490 00:49:14,174 --> 00:49:16,610 TYPICALLY AS YOU SAID, WE OFTEN 1491 00:49:16,610 --> 00:49:18,212 CONSIDER JUST THAT UP TO THE ONE 1492 00:49:18,212 --> 00:49:20,781 YEAR, RIGHT, POST BIRTH. 1493 00:49:20,781 --> 00:49:23,083 SO DO YOU KNOW IF THERE ARE ANY 1494 00:49:23,083 --> 00:49:25,986 STUDIES THAT HAVE BEEN PUBLISHED 1495 00:49:25,986 --> 00:49:27,621 LINKING PERINATAL HEALTH TO 1496 00:49:27,621 --> 00:49:28,489 CARDIOVASCULAR HEALTH, EITHER 1497 00:49:28,489 --> 00:49:32,259 DURING THE MENOPAUSAL TRANSITION 1498 00:49:32,259 --> 00:49:33,193 OR POST-MENOPAUSAL PERIODS? 1499 00:49:33,193 --> 00:49:35,496 >> IT'S A REALLY GREAT QUESTION, 1500 00:49:35,496 --> 00:49:37,765 AND I THINK IT HELPS TO 1501 00:49:37,765 --> 00:49:38,432 CONCEPTUALIZE THAT FULL LIFE 1502 00:49:38,432 --> 00:49:39,733 COURSE APPROACH, WHERE WE'RE 1503 00:49:39,733 --> 00:49:41,502 THINKING ABOUT PREGNANCY AND 1504 00:49:41,502 --> 00:49:43,370 MENOPAUSE AS BOTH BEING REALLY 1505 00:49:43,370 --> 00:49:46,473 KEY LIFE EVENTS IN A 1506 00:49:46,473 --> 00:49:47,107 PREGNANCY-CAPABLE INDIVIDUAL 1507 00:49:47,107 --> 00:49:48,108 WHEN SIGNIFICANT METABOLIC 1508 00:49:48,108 --> 00:49:48,976 CHANGES ARE HAPPENING. 1509 00:49:48,976 --> 00:49:50,778 I THINK BOTH OF THOSE 1510 00:49:50,778 --> 00:49:53,714 TRANSITIONS ARE OFTEN KIND OF 1511 00:49:53,714 --> 00:49:56,250 ASSOCIATED WITH ADVERSE CHANGES 1512 00:49:56,250 --> 00:49:57,818 IN CARDIOMETABOLIC FACTORS, BUT 1513 00:49:57,818 --> 00:49:58,686 IT'S STILL UNCLEAR WHETHER OR 1514 00:49:58,686 --> 00:50:00,387 NOT THOSE ARE MARKERS OR 1515 00:50:00,387 --> 00:50:01,588 MEDIATORS OF THOSE CHANGES THAT 1516 00:50:01,588 --> 00:50:02,990 ARE OCCURRING THEN. 1517 00:50:02,990 --> 00:50:05,793 IN TERMS OF THE LINK BETWEEN 1518 00:50:05,793 --> 00:50:08,095 ADVERSE PREGNANCY OUTCOMES AND 1519 00:50:08,095 --> 00:50:09,496 MENOPAUSAL HEALTH OR 1520 00:50:09,496 --> 00:50:10,531 CARDIOMETABOLIC HEALTH OR 1521 00:50:10,531 --> 00:50:12,066 CHANGES DURING MENOPAUSE, I 1522 00:50:12,066 --> 00:50:13,834 THINK THE BEST STUDY THAT 1523 00:50:13,834 --> 00:50:17,972 PROBABLY HAS TRACKED THEM MAY BE 1524 00:50:17,972 --> 00:50:19,139 RETROSPECTIVE DATA FROM THE SWAN 1525 00:50:19,139 --> 00:50:20,441 STUDY LOOKING AT INDIVIDUALS WHO 1526 00:50:20,441 --> 00:50:22,076 HAVE HYPERTENSIVE DISORDERS OF 1527 00:50:22,076 --> 00:50:24,244 PREGNANCY, HAVING WORSE 1528 00:50:24,244 --> 00:50:25,512 CARDIOMETABOLIC HEALTH AROUND 1529 00:50:25,512 --> 00:50:26,480 THE PERIMENOPAUSAL TRANSITION, 1530 00:50:26,480 --> 00:50:29,249 BUT I DO THINK THE NEW MOM TO BE 1531 00:50:29,249 --> 00:50:31,151 HEART HEALTH STUDY, NOT JUST 1532 00:50:31,151 --> 00:50:32,353 BIASED BECAUSE I WORK WITH THEM, 1533 00:50:32,353 --> 00:50:34,989 IS REALLY VERY WELL POSITIONED 1534 00:50:34,989 --> 00:50:37,024 RIGHT NOW AS MANY OF THOSE 1535 00:50:37,024 --> 00:50:38,325 INDIVIDUALS ARE ABOUT TO 1536 00:50:38,325 --> 00:50:41,161 TRANSITION AND GO THROUGH THAT 1537 00:50:41,161 --> 00:50:42,629 PERIMENOPAUSAL PERIOD, HAVING 1538 00:50:42,629 --> 00:50:44,732 HAD FOLLOW-UP FROM THEIR FIRST 1539 00:50:44,732 --> 00:50:46,033 PREGNANCY SO BEING ABLE TO 1540 00:50:46,033 --> 00:50:48,569 REALLY START THEM AT A 1541 00:50:48,569 --> 00:50:49,903 MEASUREMENT OF CARDIOVASCULAR 1542 00:50:49,903 --> 00:50:51,905 HEALTH AT THAT FIRST PERIOD WITH 1543 00:50:51,905 --> 00:50:53,741 RIGOROUS ADJUDICATION OF ADVERSE 1544 00:50:53,741 --> 00:50:55,075 PREGNANCY OUTCOME STATUS AND NOW 1545 00:50:55,075 --> 00:50:56,243 COMING INTO THAT TRANSITION. 1546 00:50:56,243 --> 00:50:58,212 SO I THINK THAT COHORT IS REALLY 1547 00:50:58,212 --> 00:50:59,747 GOING TO TEACH US A LOT FOR THE 1548 00:50:59,747 --> 00:51:00,681 QUESTIONS YOU'RE ASKING. 1549 00:51:00,681 --> 00:51:02,082 >> WONDERFUL. 1550 00:51:02,082 --> 00:51:03,951 AND YOU READ MY MIND, I ALSO HAD 1551 00:51:03,951 --> 00:51:07,187 NEW MOM TO BE IN MY PURVIEW. 1552 00:51:07,187 --> 00:51:09,490 CAN YOU REMIND THE AUDIENCE THE 1553 00:51:09,490 --> 00:51:12,559 AGE AND SORT OF THE -- WHEN WE 1554 00:51:12,559 --> 00:51:15,662 MIGHT EXPECT TA THAT TYPE OF 1555 00:51:15,662 --> 00:51:16,897 RESEARCH CAN BE DONE 1556 00:51:16,897 --> 00:51:17,731 SPECIFICALLY IN THE NEW MOM TO 1557 00:51:17,731 --> 00:51:18,532 BE COHORT? 1558 00:51:18,532 --> 00:51:19,600 >> YEAH, THAT'S A GREAT 1559 00:51:19,600 --> 00:51:20,634 QUESTION. 1560 00:51:20,634 --> 00:51:22,636 I THINK THE MEAN AGE RIGHT NOW 1561 00:51:22,636 --> 00:51:23,737 FOR THE NEW MOM TO BE HEART 1562 00:51:23,737 --> 00:51:25,472 HEALTH STUDY PARTICIPANTS IS 1563 00:51:25,472 --> 00:51:29,043 SOMEWHERE AROUND 35 TO 40. 1564 00:51:29,043 --> 00:51:31,445 AND WE WOULD EXPECT MOST 1565 00:51:31,445 --> 00:51:34,314 INDIVIDUALS TO TRANSITION TO 1566 00:51:34,314 --> 00:51:36,050 MENOPAUSE SOMEWHERE BETWEEN 55 1567 00:51:36,050 --> 00:51:38,185 TO 60, ALTHOUGH PREMATURE 1568 00:51:38,185 --> 00:51:39,820 MENOPAUSE, I THINK TO HIGHLIGHT 1569 00:51:39,820 --> 00:51:41,889 YOUR POINT, OCCURRING EITHER 1570 00:51:41,889 --> 00:51:44,158 BEFORE 40 OR BEFORE 45, HAS ALSO 1571 00:51:44,158 --> 00:51:46,326 BEEN HIGHLIGHTED AS A 1572 00:51:46,326 --> 00:51:47,728 RISK-ENHANCING FACTOR FOR 1573 00:51:47,728 --> 00:51:48,629 CARDIOVASCULAR DISEASE, SO WE'RE 1574 00:51:48,629 --> 00:51:50,531 NOT THAT FAR AWAY FROM TRACKING 1575 00:51:50,531 --> 00:51:52,533 AND LOOKING AT THIS AND I KNOW 1576 00:51:52,533 --> 00:51:57,304 THEY ARE COLLECTING INFORMATION 1577 00:51:57,304 --> 00:51:59,807 ON PREGNANCY -- FOLLOW-UP 1578 00:51:59,807 --> 00:52:01,008 PREGNANCIES AS WELL AS ANY 1579 00:52:01,008 --> 00:52:01,975 MENOPAUSAL SYMPTOMS THAT MAY BE 1580 00:52:01,975 --> 00:52:04,711 COMING IN TERMS OF PERIOD 1581 00:52:04,711 --> 00:52:05,879 IRREGULARITY. 1582 00:52:05,879 --> 00:52:07,081 >> THANK YOU. 1583 00:52:07,081 --> 00:52:08,916 SO I SEE WE HAVE SEVERAL 1584 00:52:08,916 --> 00:52:11,218 QUESTIONS FROM THE AUDIENCE. 1585 00:52:11,218 --> 00:52:13,487 THE FIRST ONE, WHAT ROLE DOES 1586 00:52:13,487 --> 00:52:15,789 CVD SCREENING PLAY IN ENSURING 1587 00:52:15,789 --> 00:52:17,858 PATIENTS KNOW THEIR CVD STATUS? 1588 00:52:17,858 --> 00:52:20,094 AND DO YOU KNOW OF ANY VALIDATED 1589 00:52:20,094 --> 00:52:22,529 AND RECOMMENDED SCREENING TOOLS 1590 00:52:22,529 --> 00:52:24,832 WE SHOULD INCORPORATE INTO OUR 1591 00:52:24,832 --> 00:52:25,599 PERIPARTUM VISITS? 1592 00:52:25,599 --> 00:52:27,267 >> YEAH, I THINK THAT'S A GREAT 1593 00:52:27,267 --> 00:52:27,701 QUESTION. 1594 00:52:27,701 --> 00:52:30,537 AND DEFINITELY AN AREA WHERE 1595 00:52:30,537 --> 00:52:32,539 HAVING GUIDELINES THAT ARE 1596 00:52:32,539 --> 00:52:34,875 SPECIFIC TO EXACTLY WHEN AN 1597 00:52:34,875 --> 00:52:36,643 INDIVIDUAL SHOULD HAVE 1598 00:52:36,643 --> 00:52:37,945 CARDIOVASCULAR DISEASE SCREENING 1599 00:52:37,945 --> 00:52:40,013 AFTER PREGNANCY COULD BE REALLY 1600 00:52:40,013 --> 00:52:40,547 HELPFUL. 1601 00:52:40,547 --> 00:52:43,450 RIGHT NOW, THE GENERAL GUIDANCE 1602 00:52:43,450 --> 00:52:46,220 OR RECOMMENDATION IS AFTER THAT 1603 00:52:46,220 --> 00:52:47,421 3 TO 6 MONTH POSTPARTUM PERIOD 1604 00:52:47,421 --> 00:52:49,223 TO CONSIDER AN ASSESSMENT OF 1605 00:52:49,223 --> 00:52:50,657 CARDIOVASCULAR DISEASE RISK 1606 00:52:50,657 --> 00:52:53,827 FACTORS AND I THINK THE LIFE'S 1607 00:52:53,827 --> 00:52:54,461 ESSENTIAL EIGHT CARDIOVASCULAR 1608 00:52:54,461 --> 00:52:55,529 HEALTH FRAMEWORK IS A GREAT WAY 1609 00:52:55,529 --> 00:52:57,264 TO APPROACH THAT TO CONSIDER 1610 00:52:57,264 --> 00:52:58,732 WHAT SOMEONE'S CARDIOVASCULAR 1611 00:52:58,732 --> 00:53:00,467 HEALTH SCORE IS AND GOING 1612 00:53:00,467 --> 00:53:03,103 THROUGH AND ASSESSING THAT AS A 1613 00:53:03,103 --> 00:53:05,672 WAY TO MEASURE CARDIOVASCULAR 1614 00:53:05,672 --> 00:53:07,274 HEALTH AND THINK ABOUT 1615 00:53:07,274 --> 00:53:08,876 INTERVENTIONS TO THEN IMPROVE 1616 00:53:08,876 --> 00:53:11,211 CARDIOVASCULAR HEALTH. 1617 00:53:11,211 --> 00:53:13,247 THE PREVENT RISK SCORE IS 1618 00:53:13,247 --> 00:53:14,581 ANOTHER WAY TO THINK WITH 1619 00:53:14,581 --> 00:53:15,849 PREDICTED RISK THAT CAN ALSO BE 1620 00:53:15,849 --> 00:53:18,385 DONE FOR ADULTS 30 AND OLDER. 1621 00:53:18,385 --> 00:53:21,088 >> GREAT, THANK YOU. 1622 00:53:21,088 --> 00:53:22,923 WHY OR HOW DO YOU THINK 1623 00:53:22,923 --> 00:53:25,526 LACTATION IS RELATED TO IMPROVED 1624 00:53:25,526 --> 00:53:26,126 CARDIOMETABOLIC HEALTH OTHER 1625 00:53:26,126 --> 00:53:27,728 THAN THROUGH WEIGHT LOSS 1626 00:53:27,728 --> 00:53:28,028 POSTPARTUM? 1627 00:53:28,028 --> 00:53:30,097 >> YEAH, I THINK THAT'S A GREAT 1628 00:53:30,097 --> 00:53:30,964 QUESTION IN TERMS OF WHAT ARE 1629 00:53:30,964 --> 00:53:33,133 THE MECHANISMS THROUGH WHICH 1630 00:53:33,133 --> 00:53:34,835 LACTATION CAN IMPROVE 1631 00:53:34,835 --> 00:53:36,270 CARDIOMETABOLIC HEALTH AND I 1632 00:53:36,270 --> 00:53:38,138 THINK A LARGE PART OF IT IS 1633 00:53:38,138 --> 00:53:39,339 THROUGH THE ENERGY EXPENDITURE 1634 00:53:39,339 --> 00:53:42,009 THAT MAY BE RELATED TO WEIGHT 1635 00:53:42,009 --> 00:53:45,078 LOSS AND PARTICULARLY ACHIEVING 1636 00:53:45,078 --> 00:53:46,079 PREPREGNANCY WEIGHT, BECAUSE WE 1637 00:53:46,079 --> 00:53:47,948 KNOW THAT INDIVIDUALS WHO ARE 1638 00:53:47,948 --> 00:53:49,616 NOT ABLE TO RETURN TO THEIR 1639 00:53:49,616 --> 00:53:50,918 PREPREGNANCY WEIGHT OR HAVE 1640 00:53:50,918 --> 00:53:52,586 WEIGHT GAIN POSTPARTUM ARE MUCH 1641 00:53:52,586 --> 00:53:54,321 MORE LIKELY TO DEVELOP 1642 00:53:54,321 --> 00:53:56,023 HYPERTENSION AND DIABETES IN 1643 00:53:56,023 --> 00:54:00,194 THAT POSTPARTUM PERIOD. 1644 00:54:00,194 --> 00:54:00,961 >> GREAT. 1645 00:54:00,961 --> 00:54:02,596 YOU TOUCHED ON THIS A LITTLE BIT 1646 00:54:02,596 --> 00:54:04,164 ALREADY, BUT ARE THERE ANY 1647 00:54:04,164 --> 00:54:07,634 VALIDATED MEASURES FOR 1648 00:54:07,634 --> 00:54:08,302 CARDIOMETABOLIC DISEASE THAT WE 1649 00:54:08,302 --> 00:54:10,237 SHOULD USE TO TRACK A PATIENT'S 1650 00:54:10,237 --> 00:54:13,807 PROGRESS AND HAS LIFE'S 1651 00:54:13,807 --> 00:54:15,309 ESSENTIAL 8 BEEN USED FOR THAT 1652 00:54:15,309 --> 00:54:16,643 PURPOSE, BEEN VALIDATED FOR THIS 1653 00:54:16,643 --> 00:54:16,877 PURPOSE? 1654 00:54:16,877 --> 00:54:17,945 >> THAT'S A GREAT QUESTION. 1655 00:54:17,945 --> 00:54:19,913 I THINK THE LIFE'S ESSENTIAL 1656 00:54:19,913 --> 00:54:22,549 8 SCORE IS A GREAT ONE TO ANCHOR 1657 00:54:22,549 --> 00:54:25,886 ON BECAUSE IT HELPS TO CREATE A 1658 00:54:25,886 --> 00:54:27,521 COMPOSITE SCORE AROUND THE 1659 00:54:27,521 --> 00:54:28,622 CARDIOMETABOLIC FACTORS. 1660 00:54:28,622 --> 00:54:30,357 THE CARDIOVASCULAR KIDNEY 1661 00:54:30,357 --> 00:54:31,291 METABOLIC CONSTRUCT THAT I 1662 00:54:31,291 --> 00:54:33,927 INTRODUCED AT THE END REALLY 1663 00:54:33,927 --> 00:54:35,996 INTEGRATES THE LIFE'S ESSENTIAL 1664 00:54:35,996 --> 00:54:37,598 8 IN CARDIOVASCULAR HEALTH SCORE 1665 00:54:37,598 --> 00:54:39,333 WITH QUANTITATIVE RISK SCORING 1666 00:54:39,333 --> 00:54:41,535 FROM PREVENT TO ALLOW A MORE 1667 00:54:41,535 --> 00:54:42,636 QUALITATIVE STAGING APPROACH, 1668 00:54:42,636 --> 00:54:44,104 WITH YOU MAY BE CONSIDERED, BUT 1669 00:54:44,104 --> 00:54:46,306 I THINK RIGHT NOW, WE HAVE MUCH 1670 00:54:46,306 --> 00:54:47,941 MORE DATA ON THE LIFE'S 1671 00:54:47,941 --> 00:54:51,845 ESSENTIAL 8 SCORING APPROACH. 1672 00:54:51,845 --> 00:54:53,146 >> GREAT. 1673 00:54:53,146 --> 00:54:55,782 LET'S SEE. 1674 00:54:55,782 --> 00:54:57,751 ONE AUDIENCE MEMBER STATED THANK 1675 00:54:57,751 --> 00:54:59,886 YOU FOR A WONDERFUL LIFE COURSE 1676 00:54:59,886 --> 00:55:01,321 DISCUSSION AROUND PREGNANCY AND 1677 00:55:01,321 --> 00:55:02,522 PREGNANCY OUTCOMES. 1678 00:55:02,522 --> 00:55:04,825 WHAT DO YOU FEEL IS THE MOST 1679 00:55:04,825 --> 00:55:05,759 PROMISING INTERVENTION DURING 1680 00:55:05,759 --> 00:55:07,628 THE PREPREGNANCY OR 1681 00:55:07,628 --> 00:55:08,395 INTERPREGNANCY PERIODS TO 1682 00:55:08,395 --> 00:55:10,597 PREVENT OR REDUCE RISK FOR LONG 1683 00:55:10,597 --> 00:55:12,099 TERM CARDIOVASCULAR HEALTH IN 1684 00:55:12,099 --> 00:55:13,700 WOMEN WHO EXPERIENCE APOs 1685 00:55:13,700 --> 00:55:14,368 DURING PREGNANCY? 1686 00:55:14,368 --> 00:55:16,003 WOULD THIS INCLUDE MEDICATIONS, 1687 00:55:16,003 --> 00:55:17,371 ESSER SEISE, DIET OR ANYTHING 1688 00:55:17,371 --> 00:55:17,571 ELSE? 1689 00:55:17,571 --> 00:55:19,439 >> IT'S A REALLY, REALLY TOUGH 1690 00:55:19,439 --> 00:55:20,874 QUESTION, AND I THINK THE ANSWER 1691 00:55:20,874 --> 00:55:25,879 IS PROBABLY COMPLICATED AND 1692 00:55:25,879 --> 00:55:26,847 PERHAPS ONE OF THE THINGS THAT 1693 00:55:26,847 --> 00:55:28,548 MAY BE MOST HELPFUL IS THINKING 1694 00:55:28,548 --> 00:55:29,883 ABOUT A BIT OF A PRECISION 1695 00:55:29,883 --> 00:55:32,686 APPROACH WITH THIS QUESTION. 1696 00:55:32,686 --> 00:55:34,321 SO ARE THERE STRATEGIES THAT MAY 1697 00:55:34,321 --> 00:55:36,189 BE MORE TAILORED TO SPECIFIC 1698 00:55:36,189 --> 00:55:37,891 INDIVIDUALS THAT COULD HELP WITH 1699 00:55:37,891 --> 00:55:39,426 THIS, AND I THINK ABOUT 1700 00:55:39,426 --> 00:55:41,194 INDIVIDUALS WHO HAVE MAYBE 1701 00:55:41,194 --> 00:55:42,629 SIGNAL OF ELEVATED BLOOD 1702 00:55:42,629 --> 00:55:45,232 PRESSURE AND THINKING ABOUT LOW 1703 00:55:45,232 --> 00:55:46,500 SODIUM DIET INTERVENTION AND 1704 00:55:46,500 --> 00:55:48,502 PHYSICAL ACTIVITY INTERVENTION 1705 00:55:48,502 --> 00:55:50,237 VERSUS AN INDIVIDUAL WHO MAYBE 1706 00:55:50,237 --> 00:55:53,140 HAS SEVERE OBESITY AND ARE THERE 1707 00:55:53,140 --> 00:55:54,441 MEDICATIONS PARTICULARLY AS WE 1708 00:55:54,441 --> 00:55:57,978 LEARN MORE ABOUT GLUCAGON 1709 00:55:57,978 --> 00:55:59,746 RECEPTOR PEPTIDE ONE AGONISTS AS 1710 00:55:59,746 --> 00:56:01,415 A POTENTIAL APPROACH FOR 1711 00:56:01,415 --> 00:56:02,949 CONSIDERING EARLIER INTERVENTION 1712 00:56:02,949 --> 00:56:04,251 OR SHORT TERM USE IN THE SETTING 1713 00:56:04,251 --> 00:56:05,652 OF SEVERE OBESITY. 1714 00:56:05,652 --> 00:56:08,055 SO I THINK REALLY GOOD QUESTION, 1715 00:56:08,055 --> 00:56:09,723 AND PERHAPS ONE WHERE WE REALLY 1716 00:56:09,723 --> 00:56:13,827 NEED TO FOCUS A LOT OF THOUGHT 1717 00:56:13,827 --> 00:56:15,262 IN TERMS OF HOW WE WOULD EVEN 1718 00:56:15,262 --> 00:56:16,563 DESIGN THESE TYPES OF TRIALS 1719 00:56:16,563 --> 00:56:19,232 GIVEN THE CHALLENGE OF 1720 00:56:19,232 --> 00:56:19,800 IDENTIFYING PRE-PREGNANT 1721 00:56:19,800 --> 00:56:20,567 INDIVIDUALS AND THEN CONSIDERING 1722 00:56:20,567 --> 00:56:22,502 HOW WE WOULD MACH TRIAL DESIGN 1723 00:56:22,502 --> 00:56:23,704 WITH THE PHENOTYPE OF THE 1724 00:56:23,704 --> 00:56:27,607 INDIVIDUAL. 1725 00:56:27,607 --> 00:56:29,843 >> ANOTHER AUDIENCE MEMBER SAYS 1726 00:56:29,843 --> 00:56:30,477 GREAT PRESENTATION. 1727 00:56:30,477 --> 00:56:32,546 IT WAS FASCINATING TO SEE THE 1728 00:56:32,546 --> 00:56:33,747 GRAPH IN THE STUDY SHOWING THE 1729 00:56:33,747 --> 00:56:40,053 BURDEN OF YOUNGER GENERATIONS AE 1730 00:56:40,053 --> 00:56:40,520 HAVING. 1731 00:56:40,520 --> 00:56:42,122 DO YOU NOW STUDIES THAT EXPLORE 1732 00:56:42,122 --> 00:56:45,192 THE DIFFERENT RISK FACTOR BURDEN 1733 00:56:45,192 --> 00:56:45,859 AMONG GENERATIONS? 1734 00:56:45,859 --> 00:56:47,794 >> IT'S A GREAT QUESTION. 1735 00:56:47,794 --> 00:56:50,497 I THINK THERE'S BEEN KIND OF -- 1736 00:56:50,497 --> 00:56:52,232 PERHAPS SOME OBSERVATIONAL 1737 00:56:52,232 --> 00:56:53,200 ANALYSES THAT COULD BE 1738 00:56:53,200 --> 00:56:54,534 CONSIDERED THINKING ABOUT THAT, 1739 00:56:54,534 --> 00:56:56,136 LIKE THE COLLABORATIVE PERINATAL 1740 00:56:56,136 --> 00:56:59,740 PROJECT OR CPP IS ONE THAT'S 1741 00:56:59,740 --> 00:57:01,274 FROM FIVE DECADES AGO, AND IF WE 1742 00:57:01,274 --> 00:57:03,443 COMPARE THAT TO SOME 1743 00:57:03,443 --> 00:57:04,511 CONTEMPORARY COHORTS TODAY, WE 1744 00:57:04,511 --> 00:57:06,179 MAY BE ABLE TO SEE SOME 1745 00:57:06,179 --> 00:57:06,613 PATTERNS. 1746 00:57:06,613 --> 00:57:08,148 ONE OF THE BIGGEST CHALLENGES IS 1747 00:57:08,148 --> 00:57:09,616 THAT DEFINITION OF SOME OF THESE 1748 00:57:09,616 --> 00:57:10,417 COMPLICATIONS HAS CHANGED OVER 1749 00:57:10,417 --> 00:57:11,685 TIME AS WELL. 1750 00:57:11,685 --> 00:57:13,520 IN MORE RECENT YEARS OR RECENT 1751 00:57:13,520 --> 00:57:14,621 GENERATIONS, I DON'T THINK THAT 1752 00:57:14,621 --> 00:57:16,590 THAT'S THE DRIVER, BUT WE REALLY 1753 00:57:16,590 --> 00:57:18,258 NEED LONGITUDAL OBSERVATIONAL 1754 00:57:18,258 --> 00:57:20,594 DATA THAT ALLOW US TO FOLLOW THE 1755 00:57:20,594 --> 00:57:22,462 SAME INDIVIDUAL TO BETTER 1756 00:57:22,462 --> 00:57:24,898 UNDERSTAND IF THOSE RISK FACTOR 1757 00:57:24,898 --> 00:57:27,134 CHANGES ARE WHAT ARE ASSOCIATED 1758 00:57:27,134 --> 00:57:30,837 WITH INCREASING RISK. 1759 00:57:30,837 --> 00:57:33,340 >> GREAT. 1760 00:57:33,340 --> 00:57:36,076 SOMEONE HAS RAISED THE QUESTION 1761 00:57:36,076 --> 00:57:37,344 AROUND TOBACCO, THIS IS GREAT. 1762 00:57:37,344 --> 00:57:38,345 THEY SAY GREAT TALK. 1763 00:57:38,345 --> 00:57:41,715 CAN YOU COMMENT ON THE ROLE OF 1764 00:57:41,715 --> 00:57:42,616 SMOKING, TOBACCO CESSATION IN 1765 00:57:42,616 --> 00:57:44,751 THE EARLY PREVENTION OF 1766 00:57:44,751 --> 00:57:45,419 CARDIOVASCULAR HEALTH IN MOTHERS 1767 00:57:45,419 --> 00:57:45,786 AND CHILDREN? 1768 00:57:45,786 --> 00:57:47,387 >> YEAH, I THINK THIS IS A GREAT 1769 00:57:47,387 --> 00:57:51,925 QUESTION AND ONE WHERE WE'VE HAD 1770 00:57:51,925 --> 00:57:53,226 A LOT OF SUCCESS IN TERMS OF 1771 00:57:53,226 --> 00:57:55,529 TOBACCO CESSATION AND NOW 1772 00:57:55,529 --> 00:57:57,731 PERHAPS WITH VAPING AND 1773 00:57:57,731 --> 00:57:58,865 E-CIGARETTES, WE'RE SEEING AN 1774 00:57:58,865 --> 00:58:00,167 INCREASING PREVALENCE AGAIN IN 1775 00:58:00,167 --> 00:58:03,136 YOUNG ADULTS OF USE OF TOBACCO 1776 00:58:03,136 --> 00:58:06,106 OR E-CIGARETTE PRODUCTS. 1777 00:58:06,106 --> 00:58:07,140 WE KNOW THOSE ARE ASSOCIATED 1778 00:58:07,140 --> 00:58:08,742 WITH POOR CARDIOVASCULAR HEALTH 1779 00:58:08,742 --> 00:58:09,910 AND I THINK WE'RE STILL 1780 00:58:09,910 --> 00:58:11,711 GENERATING EVIDENCE IN TERMS OF 1781 00:58:11,711 --> 00:58:12,345 UNDERSTANDING SPECIFICALLY FOR 1782 00:58:12,345 --> 00:58:14,648 TOBACCO AND MARIJUANA USE AND 1783 00:58:14,648 --> 00:58:16,283 OTHER E-CIGARETTES THE EXACT 1784 00:58:16,283 --> 00:58:17,818 IMPACT ON CARDIOVASCULAR HEALTH 1785 00:58:17,818 --> 00:58:18,919 FOR BIRTHING INDIVIDUALS AND 1786 00:58:18,919 --> 00:58:20,187 OFFSPRING, BUT I THINK THIS IS A 1787 00:58:20,187 --> 00:58:21,087 REALLY IMPORTANT AREA OF 1788 00:58:21,087 --> 00:58:23,457 RESEARCH. 1789 00:58:23,457 --> 00:58:25,692 >> I THINK WE HAVE TIME FOR ONE 1790 00:58:25,692 --> 00:58:27,093 QUICK QUESTION. 1791 00:58:27,093 --> 00:58:30,030 IN THE RESEARCH YOU MENTIONED, 1792 00:58:30,030 --> 00:58:32,732 IS CAROTID ULTRASOUND USED FOR 1793 00:58:32,732 --> 00:58:34,134 ALL PREGNANT PEOPLE OR ONLY 1794 00:58:34,134 --> 00:58:35,569 THOSE WITH CARDIOVASCULAR 1795 00:58:35,569 --> 00:58:36,203 SYMPTOMS DURING PREGNANCY? 1796 00:58:36,203 --> 00:58:37,137 >> GREAT QUESTION. 1797 00:58:37,137 --> 00:58:39,806 SO THAT ANCILLARY STUDY IS BEING 1798 00:58:39,806 --> 00:58:41,575 DONE IN THE NEW MOM TO BE HEART 1799 00:58:41,575 --> 00:58:43,810 HEALTH STUDY, AND I SEE A 1800 00:58:43,810 --> 00:58:44,411 QUESTION DESCRIBING THIS, SO 1801 00:58:44,411 --> 00:58:46,880 THIS WAS A STUDY WHERE 10,000 1802 00:58:46,880 --> 00:58:48,415 INDIVIDUALS WERE FIRST RECRUITED 1803 00:58:48,415 --> 00:58:51,251 IN 2010 IN THE FIRST TRIMESTER 1804 00:58:51,251 --> 00:58:52,986 OF THEIR PREGNANCY ACROSS EIGHT 1805 00:58:52,986 --> 00:58:54,154 SITES IN THE UNITED STATES. 1806 00:58:54,154 --> 00:58:56,656 AT ABOUT TWO TO SEVEN YEARS, 1807 00:58:56,656 --> 00:58:58,492 4,000 OF THEM WERE THEN 1808 00:58:58,492 --> 00:59:01,862 RE-EXAMINED, AND NOW THERE'S A 1809 00:59:01,862 --> 00:59:03,296 SECOND IN-PERSON VISIT THAT'S 1810 00:59:03,296 --> 00:59:04,264 HAPPENING WHERE EVERYONE WHO WAS 1811 00:59:04,264 --> 00:59:05,565 PART OF THAT COHORT IS BEING 1812 00:59:05,565 --> 00:59:07,200 INVITED TO HAVE A CAROTID 1813 00:59:07,200 --> 00:59:08,401 ULTRASOUND WITH THE GOAL TO THEN 1814 00:59:08,401 --> 00:59:10,270 BE ABLE TO EXAMINE THE 1815 00:59:10,270 --> 00:59:11,238 ASSOCIATION BETWEEN ADVERSE 1816 00:59:11,238 --> 00:59:13,507 PREGNANCY OUTCOMES AND THEIR 1817 00:59:13,507 --> 00:59:16,009 VASCULAR INJURY OR POTENTIAL FOR 1818 00:59:16,009 --> 00:59:20,614 INJURY AND ATHEROSCLEROSIS 1819 00:59:20,614 --> 00:59:20,814 TODAY. 1820 00:59:20,814 --> 00:59:21,481 >> WONDERFUL. 1821 00:59:21,481 --> 00:59:22,716 WELL, THANK YOU ALL TO EVERYONE 1822 00:59:22,716 --> 00:59:24,518 WHO JOINED US TODAY AND DURING 1823 00:59:24,518 --> 00:59:26,686 THE ONPA SEMINARS THIS YEAR. 1824 00:59:26,686 --> 00:59:28,088 COULD WE PLEASE BRING UP THE 1825 00:59:28,088 --> 00:59:38,365 LAST TWO SLIDES? 1826 00:59:42,269 --> 00:59:42,636 GREAT. 1827 00:59:42,636 --> 00:59:44,471 SO WE WILL BE BACK ON 1828 00:59:44,471 --> 00:59:46,540 SEPTEMBER 9TH AT 11:00 A.M. 1829 00:59:46,540 --> 00:59:50,277 EASTERN TIME, WHEN DR. KARYN 1830 00:59:50,277 --> 00:59:52,178 ESSER WILL PRESENT ON CIRCADIAN 1831 00:59:52,178 --> 00:59:54,214 CLOCKS AND EXERCISE, PARTNERS IN 1832 00:59:54,214 --> 00:59:55,949 HEALTH, OPEN TO THE PUBLIC 1833 00:59:55,949 --> 00:59:57,117 THROUGH NIH VIDEOCAST. 1834 00:59:57,117 --> 00:59:58,218 IF YOU HAVE ANY SUGGESTIONS FOR 1835 00:59:58,218 --> 00:59:59,185 TOPICS OR SPEAKERS YOU WOULD 1836 00:59:59,185 --> 01:00:03,089 LIKE TO HEAR, FEEL FREE TO EMAIL 1837 01:00:03,089 --> 01:00:06,293 THEM TO ONPA@MAIL.NIH.GOV. 1838 01:00:06,293 --> 01:00:07,494 THANK YOU AGAIN DR. KHAN FOR 1839 01:00:07,494 --> 01:00:08,461 SHARING YOUR INSIGHTS ON THIS 1840 01:00:08,461 --> 01:00:08,895 IMPORTANT TOPIC. 1841 01:00:08,895 --> 01:00:10,530 HAVE A GREAT REST OF THE DAY, 1842 01:00:10,530 --> 01:00:10,797 EVERYONE! 1843 01:00:10,797 --> 01:00:21,041 >> THANK YOU.